Virginia Commonwealth University

VCU Scholars Compass
Theses and Dissertations

Graduate School

2008

Interneuron Subtypes are Differentially Altered in Malformed,
Epileptogenic Cortex
Amanda George
Virginia Commonwealth University

Follow this and additional works at: https://scholarscompass.vcu.edu/etd
Part of the Nervous System Commons
© The Author

Downloaded from
https://scholarscompass.vcu.edu/etd/1618

This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It
has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars
Compass. For more information, please contact libcompass@vcu.edu.

© Amanda L. George
2008
All Rights Reserved

INTERNEURON SUBTYPES ARE DIFFERENTIALLY ALTERED IN
MALFORMED, EPILEPTOGENIC CORTEX
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy in Anatomy and Neurobiology at Virginia Commonwealth
University.

by
Amanda L. George
B.A. Duke University, 2001

Director: Kimberle Jacobs, Ph.D.
Associate Professor
Department of Anatomy and Neurobiology

Virginia Commonwealth University
Richmond, Virginia
September 15, 2008

ii

Acknowledgment

I would like to extend my thanks to those who have supported me during the
completion of my graduate studies and the writing of this dissertation. They include my
advisor, Dr. Kimberle Jacobs, my graduate committee members, Drs. Richard Costanzo,
Gordon Archer, Babette Fuss, John Povlishock and Leslie Satin, fellow members of the
Jacobs lab, members of the Povlishock lab, my friends and family.

iii

Table of Contents
Page
List of Tables .......................................................................................................................v
List of Figures .................................................................................................................... vi
List of Abbreviations ....................................................................................................... viii
Abstract .............................................................................................................................. xi
Chapter 1

Introduction to Epilepsy and Interneurons...................................................1
1.1 Epilepsy......................................................................................1
1.2 Cortical malformations ..............................................................3
1.3 Polymicrogyria...........................................................................8
1.4 Interneurons in neocortex ........................................................22
1.5 Development of interneurons...................................................34
1.6 Summary and hypothesis .........................................................38

Chapter 2

Altered Intrinsic Properties of Neuronal Subtypes in Malformed,
Epileptogenic Cortex .................................................................................41
Introduction....................................................................................41
Methods..........................................................................................44
Results............................................................................................49
Discussion ......................................................................................55

Chapter 3

Excitatory Synaptic Input to Interneurons is Differentially Affected in
Malformed, Epileptogenic Cortex, Based on Subtype...............................76
Introduction....................................................................................76
Methods..........................................................................................79
Results............................................................................................82
Discussion ......................................................................................89

Chapter 4

Introduction to Metabotropic Glutamate Receptors ................................114
4.1 Classification and function of mGluRs..................................115
4.2 Ligands for mGluRs...............................................................116
4.3 Development and expression of group I mGluRs..................119
4.4 Potential role for group I mGluRs in pathological states.......120

iv
Chapter 5

Enhanced Responsiveness of Interneurons to Group I Metabotropic
Glutamate Receptors in Malformed, Epileptogenic Cortex.....................123
Introduction..................................................................................123
Methods........................................................................................125
Results..........................................................................................128
Discussion ....................................................................................133

Chapter 6

General Discussion ..................................................................................156

List of References ............................................................................................................164
Vita...................................................................................................................................206

v

List of Tables
Table

Page

2.1

Intrinsic properties of layer V interneurons and pyramidal cells...........................62

2.2

More intrinsic properties of layer V interneurons and pyramidal cells .................63

3.1

Properties of spontaneous and miniature postsynaptic currents ............................97

5.1

Intrinsic properties of layer V pyramidal cells ....................................................141

vi

List of Figures
Figure

Page

2.1

Example traces of neuronal responses to a series of current steps ........................64

2.2

Identification of neuronal subpopulations based on action potential firing
properties................................................................................................................66

2.3

Comparison of action potential half-width in pyramidal, FS and LTS cells .........68

2.4

Confocal images of triple labeled parasagittal sections.........................................70

2.5

Confocal images of individual cells visualized with fluorescein-conjugated
biocytin ..................................................................................................................72

2.6

Altered action potential firing properties in neuronal subpopulations...................74

3.1

Excitatory post-synaptic currents in inhibitory cells .............................................98

3.2

Sample traces demonstrating typical firing patterns for LTS and FS
interneurons..........................................................................................................100

3.3

Classification of interneuron subtypes based on intrinsic properties...................102

3.4

Excitatory post-synaptic currents in FS and LTS interneurons ...........................104

3.5

Population distribution and IEI cumulative probability for mEPSCs..................106

3.6

Evoked postsynaptic currents ..............................................................................108

3.7

Interneuron response to a 50Hz train of stimuli at maximal intensity.................110

3.8

Effect of altering aCSF Mg2+ and Ca2+ concentrations on sEPSC frequency .....112

5.1

Pyramidal cell in layer V of a horizontal slice, imaged using DIC optics...........142

5.2

Effect of DHPG (10 µM) and AIDA (300 µM) on sIPSC frequency and
amplitude..............................................................................................................144

vii
5.3

Effect of Group I mGluR antagonists in bathing solution ...................................146

5.4

Effect of DHPG on sIPSC frequency with MPEP (10 mM) in bath....................148

5.5

Effect of DHPG on sIPSC frequency with AIDA (100 µM or 300 µM)
in bath...................................................................................................................150

5.6

Effect of CHPG on sIPSC frequency...................................................................152

5.7

Response of FS and LTS interneurons to DHPG application..............................154

viii

List of Abbreviations

°C

degrees Celsius

AHP

afterhyperpolarization

AIDA

1-amino-2,3-dihydro-1H-indene-1,5-dicarboxylic acid

AMPA

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

APV

D,L-2-amino-5-phosphonopentanoic acid

ATP

adenosine 5’-triphosphate

BCNU

1,2-bis-chloroethyl-nitrosourea

BDNF

brain derived neurotrophic factor

BSA

bovine serum albumin

CB

calbindin

CCK

cholecystokinin

CGE

caudal ganglionic eminence

CNS

central nervous system

CO

cytochrome oxidase

CO2

carbon dioxide

CR

calretinin

DHPG

S-3,5-dihydroxyphenylglycine hydrate

DIC

differential interference contrast

ix
DNQX

dinitroquinoxaline [(6,7)],2,3(1H,4H)-dione

e-

evoked

EC50

half maximal effective concentration

EGTA

ethylene glycol tetra-acetic acid

EPSC

excitatory postsynaptic current

FS

fast-spiking

GABA

γ-aminobutyric acid

GTP

guanosine 5’-triphosphate

Hz

hertz

IL

interleukin

IPSC

inhibitory postsynaptic current

LGE

lateral ganglionic eminence

LTP

long term potentiation

LTS

low threshold-spiking

m-

miniature

MAM

methylazoxymethanol

MGE

medial ganglionic eminence

mGluR

metabotropic glutamate receptor

MGN

medial geniculate nucleus

mM

millimolar

mOsm

milliosmolar

MPEP

6-methyl-2-(phenylethynyl) pyridine hydrochloride

x
mRNA

messenger ribonucleic acid

msec

millisecond

mV

millivolt

nA

nanoampere

NGS

normal goat serum

NMDA

N-methyl-D-aspartate

NPY

neuropeptide Y

O2

oxygen

P

postnatal day

PMG

paramicrogyral

PV

parvalbumin

Ra

access resistance

s-

spontaneous

SS

somatostatin

TBS

tris-buffered saline

TTX

tetrodotoxin

VIP

vasoactive intestinal peptide

µm

micrometer

µM

micromolar

Abstract

INTERNEURON SUBTYPES ARE DIFFERENTIALLY ALTERED IN
MALFORMED, EPILEPTOGENIC CORTEX
by Amanda L. George
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2008
Director: Kimberle Jacobs, Ph.D.
Associate Professor, Department of Anatomy and Neurobiology

The propensity for seizures in patients with epilepsy is due to underlying cortical
hyperexcitability, the mechanisms for which are poorly understood. Particularly difficult
to treat are patients with developmental malformations of cortex. Using the freeze-lesion
rat model of one such malformation, polymicrogyria, we identified, in lesioned cortex,
alterations in specific interneuron subpopulations that may promote hyperexcitability.
Previous studies demonstrate increased excitatory input to the paramicrogyral region. An
increase in the frequency of spontaneous excitatory postsynaptic currents (sEPSCs)
recorded from pyramidal cells has also been shown. We report an increase in sEPSCs
recorded from one subtype of interneuron, the low threshold-spiking interneuron (LTS),
while sEPSCs in the fast-spiking (FS) interneuron remain unchanged. Distributed
equally to pyramidal cells and interneurons, extra excitatory afferents should simply

increase overall activity level but maintain the balance of excitation and inhibition.
Selective changes in one or more interneuron subpopulations could allow inhibition to
appear unchanged, while permitting problematic alterations in inhibitory circuitry.
In what appears to be a morphological division of labor, interneurons with
intralaminar orientations are typically characterized as FS, while intracolumnar
orientations are associated with LTS cells. These cells are clearly distinguished by a
combination of visual identification and electrophysiological and intrinsic properties. We
report that these characteristics are unchanged in lesioned cortex, indicating that the
malformation is not responsible for intrinsic alteration of the cell types. However, some
firing properties demonstrate slight differences that may, in cooperation with the altered
level of input, amplify the pro-epileptogenic changes in circuitry. Finally, we also report
that there is anomalous expression of metabotropic glutamate receptors (mGluR) in
malformed cortex. Our data show that the expression of mGluR5, normally causing no
functional response in control cortex, contributes to the activation of interneurons in
paramicrogyral (PMG) cortex. These findings provide new insight to the mechanisms of
cortical hyperexcitability and identify a possible target for future pharmacological
intervention.

Chapter 1
Introduction to Epilepsy and Interneurons

1.1 Epilepsy
The earliest known documentation of epilepsy is found in an ancient Babylonian
medical text, the Sakikku, where it is referred to as the “falling disease” (101).
Throughout history, similar phrases have been used to describe epilepsy, from ancient
Chinese and Indian texts to writings from Medieval Europe and the Renaissance. The
term “epilepsy” derives from the Greek επιλαµβανειν, or epilamvanein, meaning “to take
hold of, to seize.” In the age of Hippocrates and still in some cultures today, people have
alternately viewed seizures as episodes of demon possession or divine religious
experience. Certain that a physiological explanation would unravel the mystery of this
condition, Hippocrates himself is credited with saying that discovery of the underlying
cause of epilepsy would eliminate its “sacred” quality (101). However, it was not until
the mid-1800s that Hughlings Jackson took the first substantial steps in that direction.
He, along with Jean-Martin Charcot, Wilder Penfield, Herbert Jasper and Hans Berger
made significant contributions to the body of knowledge we currently have regarding
epilepsy. At this writing, there are explanations for a number of different epilepsies,
specifically those with genetic or acquired etiologies (39; 120; 147; 248; 309). Even so,
there are many patients whose epilepsy is poorly understood and managed (306). Despite
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advances in both diagnosis and treatment, there is still much to be learned about epilepsy
and its underlying mechanisms.
The syndrome of epilepsy consists of multiple, recurrent seizures that have no
other medical explanation. The behavioral manifestations of seizures can vary, but the
clinical symptoms are all representative of excessive, synchronous neuronal firing. The
Commission on Classification and Terminology of the International League Against
Epilepsy identifies two general seizure categories, partial and generalized (2). Partial
seizures are comprised of focal symptoms and are due to abnormal neuronal activity in a
restricted region of the brain. Patients with this type of seizure may exhibit characteristic
motor behaviors or have a specific sensory experience in the absence of the appropriate
stimulus. Alternatively, generalized seizures involve both hemispheres and may have a
more severe presentation, including loss of consciousness and postural muscle tone, often
resulting in collapse.
It is difficult to accurately assess the number of patients with epilepsy worldwide,
particularly in developing countries. However, the estimated global prevalence of
epilepsy is 8.2 per 1,000 of the general population (144). This translates into
approximately 50 million people worldwide (World Health Organization Website,
www.who.int/en/). Extrapolating data from a study in Minnesota, epilepsy affects one to
three percent of the U.S. population, with ten percent experiencing a seizure at some
point during their lifetime (145). The highest incidence of seizures tends to occur at the
extremes of life, first during the neonatal period and then again after seventy years of age
(144). Most studies reveal that males have a higher incidence of unprovoked seizures
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(144). There are numerous etiologies for seizures, including tumor, genetic
predisposition, traumatic brain injury, congenital disease, dysplasia and infectious disease
of the CNS (34; 39; 161; 194; 227). However, one study from the early eighties labeled
two-thirds of epilepsy cases as idiopathic or cryptogenic, as clear identification of an
underlying cause was not possible (144). With the development of modern imaging
techniques, it is now increasingly possible for physicians to recognize that previously
unrecognized anatomical lesions underlie seizures in a number of these patients (18; 146;
195; 334).

1.2 Cortical malformations
Malformation of the cerebral cortex during development is one of the most
common causes of intractable epilepsy, especially in children (114; 366). There are
many different malformations that span a wide range of severities, dependent on how and
when the malformation arises. The next two sections review several malformations of
cortical development and the animal models used to study them.

1.2.1 Clinical aspects and etiologies of cortical malformations
Errors that occur early in central nervous system (CNS) development may result
in the generation of too few cells or, with a similar effect, cause too many cells to die.
When this happens, there are not enough neurons and glia to populate the developing
cortex. The result is an underdeveloped brain, along with microcephaly, a condition in
which the head circumference is smaller than average by more than two standard
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deviations (20; 140). Factors that may inhibit brain growth and cause this type of lesion
include vascular insult, intrauterine infection (cytomegalovirus, rubella, and
toxoplasmosis), maternal alcohol consumption and other teratogens (3). Conversely,
increased proliferation or apoptotic failure can produce a neoplastic lesion, cortical
dysplasia or hemimegalencephaly (20; 140). Patients with hemimegalencephaly in
particular suffer from intractable seizures that start at birth, as well as hemiparesis and
developmental delay (194).
Malformations that can be attributed to improper migration rather than faulty
neuron generation include lissencephaly and heterotopia. Lissencephaly, or “smooth
brain” is a condition in which the normal gyri of the cortical surface are absent or
dramatically decreased in number. Individuals with lissencephaly exhibit an array of
neurological deficits, including mental retardation, hypotonia, difficulty feeding and
epileptic seizures (94; 115). Intellectual disability in some of these patients may occur,
secondary to intractable seizure activity (194). Several genetic mutations are associated
with lissencephaly, the most well-recognized being those in the DCX (or XLIS) and LIS1
(or PAFAH1B1) genes (137; 307). LIS1 encodes a protein subunit associated with
platelet activating factor acetylhydrolase (151; 275), while DCX encodes a protein that
may be involved in microtubule assembly and/or function. The functional correlation
between abnormalities in these gene products and their respective malformation
phenotypes is unknown. Heterotopia, on the other hand, refers to the presence of one or
more deposits of inappropriately located gray matter, usually within white matter tracts of
the brain (138; 317). The major clinical presentation associated with heterotopia includes
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mild-to-moderate intellectual disability and some form of epilepsy (98; 136). One study
showed that eighty percent of patients with periventricular nodular heterotopia presented
with seizures, the majority of them being intractable (23). Another variation of this
malformation, subcortical laminar heterotopia, is associated with the lissencephaly gene
DCX, but in the more common familial X-linked bilateral periventricular nodular
heterotopia, mutations in the FLN1 gene are responsible nearly one hundred percent of
the time (117). FLN1 encodes a protein important for cell morphology and migration
(117), so this may provide a logical correlation between protein deficiency and cortical
malformation. Heterotopia is one of the malformations more frequently observed in the
animal models described in the next section.
Also due to dysfunction of post-neurogenesis development, schizencephaly refers
to a cleft in the brain that allows aCSF to flow directly from the ventricles through two
cortical “lips,” into the subarachnoid space (20; 138; 140). If the “lips” are closed, the
patient often exhibits hemiparesis or motor delay. “Open-lipped” schizencephaly more
commonly results in hydrocephalus or seizures (194). De novo mutations of the EMX2
gene have been associated with several cases of schizencephaly, particularly those with
severe clinical presentation (48). Almost always, the schizencephalic cleft is bordered by
one or more areas of polymicrogyria. Polymicrogyria is a malformation defined by an
abundance of abnormally small gyri, and as it is the malformation most closely related to
the experiments described here, it will be discussed in detail in the next section of this
chapter.
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1.2.2 Animal models of cortical malformation
A number of techniques can be used to model in rats the cortical malformations
described above. These include, but are not limited to: genetic mutation (192),
irradiation (282), exposure to methamphetamine or other chemicals in utero (32; 84;
297), injection of a toxin (211), direct mechanical damage to the cortex (109), and, as is
used in these studies, ischemia secondary to freeze probe application (99). Similar to
human patients, the type and severity of malformation that occurs during development
depends on both the timing and nature of the insult (132). While some models involve a
loss of cells throughout the cortex due to global damage, the model employed for the
studies in this body of work involves specific elimination of deep layer neurons in
somatosensory cortex (99). Some of the models described here produce spontaneous
seizures, and all of them demonstrate in vitro hyperexcitability (232). While they each
have unique mechanisms that underlie the hyperexcitability, there are shared
characteristics between them, and it is instructive to compare the mechanisms
contributing to epileptogenesis from one model to another.
Three methods of inducing cortical malformation in utero are: irradiation (282),
1,2-bis-chloroethyl-nitrosourea (BCNU) injection (32), and methylazoxymethanol
(MAM) exposure (17). Each of these reduces cortical thickness and is usually
accompanied by some type of heterotopia (232). X-irradiation of embryonic rat pups in
utero has been used for a number of years to model cortical dysplasia. These rats have an
abnormally thin cortex, as well as disruption of the radial glia (282; 283). The γaminobutyric (GABA)ergic neuronal population is reduced in these animals (284), and
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reduced excitatory drive onto the existing GABAergic cells in the malformed cortex is
observed (367). This suggests that reduced inhibition is a major contributor to the
hyperexcitability observed in this model. Injection of MAM also results in a thinning of
the cortex, and when the injections are given early enough (E24 in ferret), disorganization
of radial glia is observed (240). Pyramidal cells located within cortical heterotopias in
these rats demonstrate excessive bursting behavior and excitability, characteristics that
promote epileptiform activity (297). The histological characteristics of the cortex in
BCNU-exposed pups are similar to those in the MAM model, including disruption of
radial glia (32).
Another animal that is used specifically to model heterotopia is the telencephalic
internal structural heterotopia (TISH) rat. This malformation is due to a genetic mutation
and has similarities with the human conditions of double cortex and subcortical band
heterotopia (192). Decreased inhibitory synaptic transmission is observed in this model
and occurs two weeks prior to the onset of seizures (352). This appears to be due to a
decreased number of inhibitory afferents, as increasing the probability of release with a
low Mg2+/high Ca2+ solution fails to “rescue” the lost inhibitory function (352). A
concomitant decrease in one specific GABAergic cell population is also seen in this
model (352). It is likely that the decreased inhibition promotes epileptogenesis, although
due to the intervening two week period prior to the onset of seizures, there are likely
other contributing factors.
Lastly, microgyria can be modeled in a number of ways. A light mechanical
disturbance of the exposed pial surface can cause a microgyral malformation (109), as

8
can exposure to methamphetamine in utero (84). Two of the more commonly used
methods of inducing microgyria are the ibotenate injection (211) model and the freezelesion model (99; 156; 157). Injection of the glutamatergic agonist ibotenic acid shortly
after birth causes the death of cells in layer V-VI of the developing rodent cortex (211).
This manipulation produces a small sulcus in the brain, mimicking the human condition
of polymicrogyria (133; 211). Hyperexcitability similar to that seen in the human
condition is observed in cortical areas surrounding the lesion (274). The freeze-lesion
model creates a similar malformation and will be considered at length in the next section.

1.3 Polymicrogyria

1.3.1 Clinical aspects and etiologies of polymicrogyria
The name “polymicrogyria” describes a malformation that comprises many
abnormally small gyri on the surface of the brain, giving it an irregular, bumpy
appearance. Seizures and mental retardation are observed in most patients with this type
of malformation (137). The etiologies of polymicrogyria are varied and include in utero
ischemic insult (108) or infection (21; 85), as well as a number of genetic mutations
(137). Current advances in medical imaging have helped to identify this malformation as
one of the causative factors for epilepsies previously classified as idiopathic (18; 195;
334). However, the epileptogenic zone of this malformation is not always confined to the
area of the visible anatomical lesion. Hyperexcitable portions of cortex surround the
lesion as well, making it difficult to definitively assign boundaries to the “damaged”
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tissue (70). The extent of polymicrogyria and the amount of cortex involved can vary
greatly between individuals, but there is usually a correlation between the size of the
lesion and the severity of clinical signs and EEG findings (340).
Some of the more common forms of polymicrogyria have stereotyped anatomical
presentations, clinical symptoms and known genetic causes. Bilateral frontal
polymicrogyria, for example, encompasses practically the entire frontal lobe and causes
epilepsy, hypotonia, mental retardation and developmental delay in children (135).
Expanding to the parietal lobe, bilateral frontoparietal polymicrogyria is associated with
developmental delay, seizures and motor deficits (66; 257). It has a demonstrated
association with mutations of GPR56, a G-protein coupled receptor that is important for
protein trafficking (258; 259). Often, microgyria is observed around the sylvian fissure,
frequently in both hemispheres. Bilateral perisylvian polymicrogyria (BPP) causes
dysarthria, facial diplegia, mental retardation and seizures (134). Epilepsy of variable
severity is associated with about sixty percent of these cases (134). The combination of
BPP, seizures and oro-motor dysfunction has been termed “congenital bilateral
perisylvian syndrome,” and clinical data has been collected from patients with this
condition for over a century (194). Finally, bilateral generalized polymicrogyria affects
multiple lobes of the bran, resulting in a severe manifestation of symptoms (67). Most
patients with the generalized form suffer from seizures, and virtually all of them have
some type of cognitive or motor delay (67). Some patients with seizures secondary to
polymicrogyria can be treated with currently available anticonvulsants, but others suffer
intractable seizures, requiring surgical intervention (199).
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1.3.2 The freeze-lesion model of microgyria
The freeze-lesion model of microgyria was first developed by Dvorak and Feit in
the late seventies and recapitulates the histopathology of human four-layered
polymicrogyria (99; 100; 100). To reproduce this, a freezing probe (-50oC) is placed on
the skull of a neonatal rat pup, creating an ischemic lesion that kills the neurons present
in the cortical plate at that time, those comprising layers IV-VI. After subsequent
development of the superficial layers is complete, a focal (~1 x 4 mm) microgyral region
of laminated cortex containing four, instead of six, cortical layers is produced (99; 100).
The superficial layers of the malformed region are similar to normal neocortical layers I
and II/III (82; 85; 99). The third layer of the microgyrus is thin and contains a few cells
with small somata that are most likely glia (99). Typically, this cell-sparse third layer
terminates abruptly at the point of contact between the microgyrus proper and the
adjacent six-layered cortex (82; 85). The fourth layer is similar to and often contiguous
with layer IVb of normal cortex (82; 85; 100).
Consistent and reproducible evidence of epileptiform activity associated with the
formation of the induced microgyrus has been demonstrated after postnatal day (P)12 in
rats (156; 157; 202). The area of cortex adjacent to the induced malformation has a
normal, six-layered histological appearance, but that is where hyperexcitability is
observed, in the form of evoked interictal-like activity (156). This region is identified as
the paramicrogyral zone (PMG). Epileptiform activity in rats that are lesioned in this
manner is similar in incidence to that of humans with polymicrogyria, about eighty
percent (19; 157).
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1.3.2.1 Behavioral effects of the freeze-lesion model, including seizure susceptibility
Rats with freeze-lesion-induced microgyria do not exhibit spontaneous seizures,
but they have demonstrated increased susceptibility to seizures caused by hyperthermia
(300). Freeze-lesioned rats require a shorter latency to attain the most severe seizure
stage (generalized convulsions) induced by an episode of hyperthermia at P10, and they
do so at a lower threshold temperature than in control (300). Additionally, freezelesioned rats develop spontaneous seizures several weeks after a hyperthermia-induced
seizure at P10, while unlesioned rats subjected to the same hyperthermia paradigm do not
(299). This model, therefore, is helpful to evaluate the propensity for seizure in the
hyperexcitable brain. This is useful because it reduces the likelihood of confusing
cortical alterations that occur in response to seizures with those that may promote them.
However, in contrast to these findings, Kellinghaus et al. found no difference in the
amount of cortical excitability in adult lesioned rats compared to control (176). This
study used an in vivo recording technique and injection of bicuculline to antagonize
inhibitory transmission and promote epileptiform activity (176). This presents a conflict
between the in vitro and in vivo studies, but it may be attributed, at least partially, to age
differences with regard to both the day of lesion induction and the day the experiments
were performed. For the hyperthermia study, lesions were performed on P1, and
hyperthermia was induced at P10, while the rats were still immature (299; 300). In
contrast, the in vivo recordings were taken from animals older than P60 that were given
lesions on P0 (176). Jacobs et al. previously showed that in the freeze lesion model,
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animals lesioned on P1 exhibit hyperexcitability well into adulthood, while animals
lesioned on P0 have a decreased incidence of epileptiform responses after P40 (157).
The physiological evaluation of seizure activity is particularly relevant to the
experiments in the following chapters, but behavioral studies have demonstrated other
deficits in this model as well. Because polymicrogyria and altered migration are also
associated with dyslexia (123; 285), behavioral studies using methods that test the
auditory processing in rat have been performed (111; 252; 287). In these studies, the rats
were tested on their ability to distinguish small silent gaps in a background of white
noise. Interestingly, it is through these studies that sex differences in have been
demonstrated in this model. For example, lesioned male rats do not perform as well as
sham animals at tasks requiring rapid auditory discrimination, but the lesioned females
show no deficit (111). There is no baseline bias, as male and female sham rats perform
the task equally well (111). To determine whether a hormonal influence provided the
female rats with an advantage, the stage of estrous was used as an independent variable,
but still no difference was detected (252; 287). Interestingly, testosterone does appear to
contribute to differential cellular effects (287), as discussed below. In general, lesioned
animals also show mild cognitive deficits compared to unlesioned rats, as demonstrated
by their performance in the Morris Water Maze (299). One behavioral study employing
this lesion in mouse somatosensory cortex revealed a post-lesional increase in
contralateral thigmotaxis, or increased scanning with the whiskers represented in the
lesioned barrel field (200). The authors suggest that this may be indicative of increased
excitation in the damaged cortex or a compensatory response to decreased cortical
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activity. This behavior resolved within one week, and other assays, such as locomotion
and exploration of a novel environment, showed no difference (200).

1.3.2.2 Cellular characteristics of the freeze-lesion model
A number of studies have explored the origin, morphology, and functional
changes that occur in the neuronal populations of the freeze-lesion model. One birthdating study shows that the cell-dense second layer of the microgyrus contains neurons
generated on embryonic day (E) 20, as well as those generated on E17 that would
normally be found in layers III/IV in un-lesioned cortex (291). Cells that populate the
superficial layers are the last to migrate into place after the lesion is made, so the fact that
they are labeled with bromodeoxyuridine injected prior to lesion formation suggests two
things. Firstly, it suggests that new neurons are not generated in response to the lesion.
Secondly, the prenatally generated neurons must migrate through or around the damaged
area to arrive at their final position in the cortex. Additionally, neurons born at an earlier
time point (E15) are not found in the lesion at all (291). Neurons generated on E15
would typically populate the deep layers of cortex, and the fact that they are absent is
consistent with the mechanism of selective cell death of deep-layer neurons in this model
(99; 291). There does appear to be some proliferative response to the injury, but the
newly generated cells also stain for glial fibrillary acidic protein and are likely reactive
astrocytes (316). The presence of these cells in the microgyrus is especially dense at the
base, but they are located in the region immediately adjacent to microgyrus as well (44).
The proliferative cells show signs of having an altered potassium buffering capacity that
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may contribute to abnormal electrical behavior in and around the gyrus (44). The
concept of altered potassium buffering has also been demonstrated in astrocytes
associated with epilepsy-related tuberous sclerosis, as modeled in the mouse (162). In
this paradigm, astrocytes have a decreased Kir current, suggesting poor potassium uptake
that is likely secondary to a reduction in mRNA and Kir channel subunit protein (162).
The resulting presence of excess extracellular potassium may contribute to
hyperexcitability and epileptiform activity. Interestingly, activated microglia have also
been observed in cases of intractable epilepsy in humans (9; 42), although this has not
been explicitly described in the freeze-lesion model. Recruitment of these cells may
occur in response to lesion formation, but microglia may also have a pro-epileptogenic
role in the form of inflammatory cytokine secretion (356). In fact, injections of
interleukin (IL) β-1 have been shown to increase seizure activity and duration in a model
of temporal lobe epilepsy (357), and increased cytokine production has been
demonstrated following status epilepticus (86). Further, blockade of the IL β-1 receptor
reduced behavioral seizures in both cases (86; 357). There are a number of potential
ways that non-neuronal cells may contribute to the mechanism of epileptogenesis, and
they have yet to be fully explored.
Several alterations in cellular components suggest that a developmental delay
occurs in the freeze-lesion model. For example, fibers that resemble radial glia have been
observed within the lesioned cortex up to the fifth postnatal week (290). As no such
fibers are found in control cortex at that time, their presence in the PMG may represent
the persistence of an immature state. Also, the normally transient Cajal-Retzius cells are
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still present in PMG cortex at P12 (331). For these reasons and others, delayed maturity
has emerged as a theme in the lesion model, as well as for cortical dysplasia in humans.
In fact, what is known as the “dysmature hypothesis” of cerebral development in suggests
that the abnormal characteristics of dysplastic cortex should bear some similarity to a
normal prenatal time point, providing some idea of when appropriate development
deviated from the typical timeline (62). One prominent characteristic of dysplastic
human cortex is the presence of morphologically abnormal cells, the large, aspiny balloon
cells and cytomegalic neurons (62). Their similarity to neurons that populate the preplate
suggests that incomplete development has allowed them to persist, even in mature cortex.
These particular cell types are not observed in the rat model of polymicrogyria, although
some subtle alterations in cell structure are seen. Within the layers of the microgyrus and
in surrounding tissue, pyramidal cells in layer II/III have simpler basal dendrites than
those in control animals (129). In contrast to this, the apical dendrites of layer V
pyramidal cells around the lesion are longer than those in control cortex (92).

1.3.2.3 Subcellular alterations of the freeze-lesion model
On the subcellular level, some receptor subunits also have atypical or immature
expression patterns in the freeze-lesion model. In one study, Redecker et al. analyzed the
optical density of immunohistochemical staining for individual GABAA receptor
subunits, revealing a decrease in all subunits in the freeze lesion model, except for α3
(273). Typically, both the α3 and α2 subunits decrease their expression by the second
postnatal week and are replaced by the α1 or α4 subunit (190). Consistent with
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Redecker’s observation, Defazio et al. suggested that there is a persistent expression of
the α2 or α3 subunit in lesioned cortex, at the expense of α1 expression (89). This was
determined indirectly with application of zolpidem, a benzodiazepine receptor type 1specific agonist. The type 1 receptor is present on the α1 subunit of the GABAA receptor,
so the fact that zolpidem insensitivity is observed suggests that the α2 or α3, but not the
α1 subunit was present in the recorded cells (89). Again, this would suggest the
prolonged expression of some subunits and a delay in the expression of others.
Autoradiography has also demonstrated decreased binding to GABA receptors in the
peri-lesional area, with normal binding levels in the surrounding cortex (374). This
means that in addition to altered subtype expression, there may also be an overall
decrease in the number of GABA receptors.
Glutamate receptors appear to be altered in this model as well, as an increase in
AMPA and kainite receptor binding has been demonstrated (374), along with enhanced
function of NR2B-containing NMDA receptors (90). The NR2B subunit is typically
expressed in the embryonic brain and joined by NR2A and NR2C by the end of the first
postnatal week (218). Augmented function of receptors with the NR2B subunit provides
further support for persistent immaturity. Similarly, when freeze-lesions are performed
in utero, there is a selective increase in NR2B immunoreactivity (335). Some of the
lesioned animals that were also exposed to electrical stimulation demonstrated further
enhancement of the NR2B expression (335). Both of these results are consistent with
increased NR2B levels in tissue taken from humans with epilepsy secondary to focal
cortical dysplasia (110). In contrast, NR2B is actually downregulated in tissue from
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patients with periventricular nodular heterotopia and subcortical band heterotopia (110).
Whether or not alterations to certain receptor subtypes occur and/or contribute to
hyperexcitability appears to be specific to the underlying type of cortical malformation.
Lastly, chloride transporters KCCl and NKCC2 also have delayed expression patterns in a
portion of the PMG cortex (316).

1.3.2.4 Altered anatomical connectivity
There are some alterations to the anatomical connectivity in PMG cortex, as has
been demonstrated through the use of neuronal tracers injected into the microgyrus,
homotopic regions of control cortex and the thalamus (129; 130). Thalamocortical fibers,
commissural fibers and afferents from local pyramidal cells demonstrate abnormal
organization in and around the microgyrus. Retrograde labeling initiated by dye injection
at the site of the lesion in adult rats was visible in cell bodies of the contralateral
infragranular cortex (129). Injections to homotopic areas in control produced retrograde
labeling that was more prevalent in the supragranular contralateral cortex (129).
Interestingly, when dye was injected in the unlesioned hemisphere of a lesioned animal,
retrograde labeling indicated that more of the afferent fibers also had cell bodies of origin
in the lower layers of the lesioned hemisphere (130). This suggests a shift towards the
deeper layers of cortex for both the origin and targets of commissural fibers. Callosal
efferents from the lesioned area also showed an increase in the density of their projection
to heterotopic areas of cortex, concomitant with the absence of some homotopic
projections (286). Rosen et al. suggest that this increase could be due to the presence of
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neurotrophic growth factors released in response to cortical injury that prevent the axonal
pruning that would typically occur during this developmental time point (286). In rats
with bilateral lesions, the volume of the corpus callosum is also reduced, suggesting that
fewer connections between the cortical hemispheres are present (346). The extent of this
decrease is largest when the lesions are made on P1, and less when lesions are performed
on P3 and P5 (346). This suggests that at early lesion dates, a number of
interhemispheric connections may be eliminated entirely.
Some thalamic nuclei, as well as the fibers that form connections between the
thalamus and lesioned cortex, are altered in this model. Although the ventrobasilar
complex is not directly affected by the freeze-lesion itself, it has fewer neurons in the
lesioned animals, and this is particularly the case for males (289). The ventrobasilar
complex normally has direct connections to somatosensory cortex; however, it loses
those reciprocal connections with the lesioned area, its afferents instead forming a dense
collection of fibers adjacent to the microgyrus itself (286). This suggests that
thalamocortical afferents originally targeting the lesioned area are rerouted to
neighboring cortex, resulting in anatomical hyperinnervation. A separate study within
lesioned barrel cortex also revealed disrupted architecture and an apparent reorganization
of afferent fibers to the PMG cortex (159). Decreased cytochrome oxidase (CO) staining
within the lesion itself and increased CO staining in the surrounding cortex supports the
idea of thalamocortical afferent reorganization (159). Additionally, within the medial
geniculate nucleus (MGN), the distribution of neuronal size is altered in male rats,
resulting in more small neurons and fewer large neurons (148). This is not observed in
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the female rat population, but this may be due to the fact that the cells are smaller to
begin with and a change would be less noticeable (148). This appears to be at least
partially affected by gonadal hormones, as females who received testosterone from E16
to P5 exhibited altered MGN neuronal size, similar to the male population (287).

1.3.2.5 Altered functional connectivity
Some of the anatomical changes described in the preceding section relate to the
observed functional alterations in this model. For example, cytoarchitectural
disturbances may underlie alterations in plasticity. While electrical stimulation in layer
IV of neocortex can successfully induce long term potentiation (LTP) in control, the same
procedure fails to do so in the disorganized PMG cortex (255). This is interesting
because stimulation of layer VI immediately elicits an NMDA-dependent LTP response
in PMG. In control, LTP is only produced by layer VI stimulation when bicuculline is
also present to provide disinhibition (255). Afferent reorganization, particularly if it
provides extra excitatory fibers to the deep layers may play a role in the altered plasticity.
At the cellular level, increased miniature excitatory postsynaptic current (mEPSC)
activity in PMG cortex compared to control also indicates that excitatory afferents are
functionally increased (160). When compared by age, PMG cells demonstrate a gradual
increase in spontaneous (s)EPSC frequency from P7 to P11 (375). This is prior to the
time point when epileptiform activity can be evoked (157), suggesting that this increase
may contribute to the onset of epileptogenesis. The mEPSCs increase in frequency as
well, further suggesting that an increased number of excitatory afferents may be present,
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although increased release probability is also possible (375). Finally, evoked (e)EPSCs
are multipeaked and have larger amplitude and greater area in PMG, providing additional
support to the idea of increased excitatory input to this area of cortex (375). In the field
potential preparation, stimulation of the cortex near the lesion (~0.5-2.5 mm from the
lesion itself but not within it) results in evoked epileptiform activity that can spread
through the cortex over several millimeters (203). However, stimulating at a point distant
to the microgyrus (approximately 3 mm away or more) does not evoke an epileptiform
response (157). This indicates that there is a specific region of cortex adjacent to the
lesion that contains the mechanism for hyperexcitability. Even when mechanically
separated from the actual lesion, epileptiform activity can be evoked form this portion of
cortex (157). Interestingly, this area of excitability coincides with the area of increased
CO staining, supporting the idea that the functional excitability is due to an increased
number of afferent fibers (159).
Inhibitory circuitry is also altered in the freeze-lesion model, and there is evidence
for both impaired and enhanced GABAergic function. A decrease in GABAA receptormediated inhibitory transmission has been observed in PMG cortex, possibly due, in part,
to weaker excitatory input onto the GABAergic cells (201). For a subset of pyramidal
cells in layer V of lesioned cortex, though, evoked inhibitory postsynaptic currents
(eIPSCs) were actually enhanced (160). In the presence of APV/DNQX, these eIPSCs
were restored to control values, indicating that the enhanced pyramidal cell eIPSC is
likely due to increased excitatory input to the inhibitory cells causing that response (160).
Also, mIPSC frequency in the PMG cortex is not altered, suggesting that if release
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probability at those terminals is maintained, there is not an alteration in the overall
number of inhibitory synapses (160).

1.3.2.6 Potential involvement of interneurons in the mechanism of hyperexcitability
associated with polymicrogyria
The conventional and logical explanation for the presence of hyperexcitability and
epilepsy in malformed cortex is increased excitatory activity. Accordingly, a functional
increase in excitation has been demonstrated in the freeze-lesion model of
polymicrogyria (160; 375), and it is supported by anatomical evidence (159). However,
as discussed above, there is evidence for the alteration of both excitatory and inhibitory
synaptic transmission (158). The delay between the increase in excitatory input to
cortical PMG pyramidal cells (375) and the onset of epileptiform activity (157) also
suggest that increased excitation alone does not account for the hyperexcitability seen in
this model. Furthermore, increased excitatory input to at least some inhibitory
postsynaptic targets has also been shown (160). Finally, recent observations support the
intriguing possibility that enhanced, not diminished inhibitory function may play a role in
the pathophysiology of epilepsy (183; 206; 268). In order to clarify the potential role for
altered inhibition in the freeze-lesion model of polymicrogyria, the experiments described
here focus on the interneurons of the neocortex.
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1.4 Interneurons in neocortex
The fundamental role of the neocortical GABAergic neuron is to modulate
excitatory output. In addition to doing this on a cell-by-cell basis, interneurons are also
able to shape the activity of larger areas of cortex due to coordinated actions as members
of chemically and electrically coupled networks. In particular, inhibitory cells are able to
“reset” the pattern of pyramidal cell firing by exerting a rhythmic hyperpolarizing
influence (74). A single interneuron has the capability to simultaneously affect several
pyramidal cells in this manner, causing a number of pyramidal cells to fire at regular
intervals, in unison (74). This type of patterned activity is referred to as “synchrony,”
and it is important for a number of cortical functions. Under physiological conditions,
these include, but are not limited to: sensory perception, the formation of sensory
representation maps, information processing, motor activity, states of consciousness, and
attention (121; 319).
Interneurons make up about twenty-five percent of the neuronal population in
neocortex and exhibit a variety of morphologies, electrophysiological properties and
molecular characteristics (153; 209). Despite this diversity, interneurons share some
common properties that differentiate them from the excitatory cells. Most definitively,
these non-pyramidal inhibitory cells use γ-aminobutyric acid (GABA) as their primary
neurotransmitter, instead of glutamate. Interneurons typically do not have an apical
dendrite, and almost all of them lack dendritic spines (209). Because their axons do not
project, as pyramidal cells do, to contralateral cortex, thalamus, or spinal cord,
interneurons are considered to be ‘local circuit neurons.’ The extent of axonal
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arborization in these cells is usually several hundred micrometers. Beyond these
similarities, the variety of interneuron characteristics enables separation of interneuron
subtypes based on distinguishing intrinsic qualities. Furthermore, the difference in
axonal projection and synapse target domains suggests that these interneuron groups may
have distinct functional roles within the neocortex. No single attribute can fully define
any one of these neurons, but a combination of characteristics can be used to classify
interneurons and begin to elucidate the functional relationships they have both with each
other and with the excitatory cells of the brain.

1.4.1 Morphology of interneuron subtypes
Nearly a century ago, Santiago Ramón y Cajal noted that interneurons, or ‘cells
with the short axon,’ did not all have the same appearance (271). Since then, these cells
have been classified based on the differences in the shape of the soma and dendritic tree,
the extent of axonal arborization, and in some cases, laminar position (1). The different
morphologies can be divided into two main groups; those with vertical or intracolumnar
orientation, and those with horizontal or intralaminar orientation. There are a number of
different cell types that are considered to be vertically-oriented. Martinotti cells, found
mainly in the deep layers of cortex, but also in layer II/III, have a clear vertical bias
(105). From the cell body of origin, Martinotti cell axons ascend to layer I where they
branch and may extend over a significant horizontal distance (105; 209). Bitufted cells,
located mainly in layers II-V, have ovoid cell bodies and vertically oriented axonal
arbors. Bipolar and double-bouquet cells have columnar axons whose distribution lies
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within narrow, radially-oriented columns of tissue (105). Their names, however, refer to
the two groups of dendritic branches that originate from opposite ends of the soma,
giving these neurons their characteristic appearance. Double-bouquet cells are largely
found in the supragranular layers and have descending axons (105). Bipolar cell axons
may originate from the cell body or a proximal dendrite and contact only a few cells
(209). Two primary classes of horizontally-oriented interneurons are the chandelier cells
and basket cells. Chandelier cells, present in all cortical layers, are named for their
distinctive morphology. Their horizontal axons have many short, vertical branches with a
number of boutons that selectively form synapses on the initial segments of pyramidal
cell axons (323). Basket cells also have intralaminar orientation. Larger cells send axons
into neighboring columns, while smaller cells have dense arborizations that form multiple
connections on neighboring cell bodies and their associated proximal dendrites (209;
360). The fact that interneurons can be divided into these two categories has functional
relevance, as different cell types may perform different roles. The vertically-oriented
cells that span the layers of cortex have the potential to provide simultaneous inhibitory
input to the neurons within a column. In contrast, the horizontally-oriented cells that
synapse on neighboring cell bodies within the same layer may provide inhibition between
columns.

1.4.2 Electrophysiological characteristics of interneuron subtypes
With regard to action potential firing patterns, interneurons may fire at a
consistent rate, have an irregular pattern, or show clear adaptation (209). Onset of action
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potential firing may be immediate, delayed, or occur in bursts (209). Of the numerous
existing firing patterns, the majority of this discussion will focus on the fast-spiking (FS)
and low threshold-spiking (LTS), as they describe the two interneuron populations that
were evaluated for these studies. Interneurons that fire a rapid train of action potentials
showing little accommodation are classified as FS cells (219). These cells also have
exceptionally short action potential half-widths of <1ms (169), and their maximum firing
frequency is approximately 330 Hz (172). Frequently they are basket cells with dense
horizontal axonal arborizations that target the somata or dendrites, or they may be
chandelier cells (172). The LTS interneurons tend to have bipolar or bitufted
morphology. LTS cells respond to depolarizing current with an initial group of
temporally close action potentials, followed by an attenuating train of action potentials
(169). LTS interneurons are also capable of firing rebound action potentials when
returned to resting membrane potential following application of a hyperpolarizing current
(169). The action potential itself is slightly longer in LTS cells (> 1ms) than in FS cells
(169), and maximum firing frequency approaches 250 Hz (172). Input resistance for LTS
interneurons (>350 MΩ) is typically higher than in FS interneurons (<350 MΩ), and LTS
resting membrane potentials tend to be more depolarized (169). The action potential
afterhyperpolarization (AHP) time to peak is shorter in FS interneurons, compared to
LTS (169). Inhibitory postsynaptic currents (IPSCs) recorded from FS cells are more
frequent, have a larger amplitude and show faster kinetics than those seen in LTS cells
(15). This may be due to differential expression of GABAA receptor subunits (15).
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Together, morphological and electrophysiological characteristics suggest an anatomical
and functional separation of intralaminar and intracolumnar inhibitory components (169).
These distinct firing patterns are not evident at birth. Studies in mice show that
during the first two postnatal weeks, populations of layer IV regular-spiking and FS
interneurons come from a single population of intermediate spiking cells (214). The
early population of cells fires low-frequency action potential trains without
accommodation or fast AHP. Characteristics of FS and RS cells begin to emerge during
the first postnatal week, and these cells are encountered with increasing frequency until
about P14 (214). Mature action potential firing patterns are dependent on a complement
of specific ion channels in the neuronal membrane. In particular, the kinetics of the
potassium-driven AHP may determine the distinctive rapid firing pattern of the FS cell.
The Kv3 family of voltage-gated potassium channels appears to be necessary for this
fast-spiking characteristic (212; 214). Comparatively, pyramidal cells lack Kv3 but do
contain Kv4 (212). The presence of mRNA for Kv3.1 is correlated with the FS
phenotype (214), and FS cells from Kv3.2 knockout mice were found to have broader
action potentials and a smaller AHPs than controls (189). Voltage-gated potassium
channels formed from these subunits are activated with depolarization, causing the action
potential to be followed by a large hyperpolarization, quickly preparing the cell to fire
another action potential. Blocking Kv3.1 and Kv3.2 with tetraethylammonium resulted
in disappearance of the typical AHP and a decreased firing rate in FS cells (104).
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1.4.3 Molecular markers of interneuron subtypes and development of their expression
Interneurons selectively express certain proteins and peptides, making cellular
content a useful characteristic for distinguishing subtypes. Three main calcium-binding
proteins used for this purpose are parvalbumin (PV), calbindin (CB), and calretinin (CR).
Peptides present in interneurons include somatostatin (SS), neuropeptide Y (NPY),
vasoactive intestinal peptide (VIP) and cholecystokinin (CCK,172; 173). Some of the
peptides also serve as co-transmitters and may be released concomitantly with GABA.
Somatostatin, for example, has been shown to inhibit the presynaptic release of both
GABA and glutamate from neurons in the rat basal forebrain (230).
Within different areas of cortex, expression of some markers can be used to
define separate, non-overlapping populations of cells. In layers II/III, V and VI, the three
major cellular markers expressed in separate interneuron populations are PV, SS and VIP
(175). CB is also prevalent in these layers, overlapping with a small percentage of PV
interneurons and a substantial portion of SS interneurons. Specifically in the deep
cortical layers, nearly the entire CB cell population also expresses SS (184). VIPcontaining interneurons may also express CCK and CR, but CR is not co-expressed with
SS or PV (60; 175). For some peptides, stereotypical morphologies can be correlated.
One group of SS interneurons has axons that ascend to layer I, giving off collateral
branches in the intervening lamina (175). This morphology is indicative of Martinotti
cells, which have been shown to express SS but never VIP or PV (209). VIP is
characteristically expressed in bipolar cells (209). The molecular markers are associated
with certain physiological cell types as well. PV expression is correlated with FS
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electrophysiology (60; 173; 175). Expression of CB (173; 175) and SS (131) are
observed in cells with LTS firing characteristics. Further, analysis of mRNA in LTS
interneurons indicates that SS is the most commonly expressed neuropeptide in those
cells (60).
The development of the molecular marker phenotype may depend on cues in the
cortical environment, as opposed to being genetically predetermined, since not all cells
that derive from the same precursor contain the same calcium-binding protein (226). One
example of this is NPY, the expression of which is a transient characteristic for some
cells in cortex. NPY is a peptide that appears to act presynaptically, preventing the
release of glutamate. It has also been shown to reduce excitation in the hippocampus
(75). During development, a number of immature interneurons are immunopositive for
NPY. Due in part to the influence of thalamocortical afferent input, the subset of these
cells that also eventually express PV shows a decrease in NPY production (359). A
change in the balance of inhibitory and excitatory input to a developing interneuron may
also have an effect on its cellular contents. In hippocampal slice culture, application of
the GABAA receptor blocker bicuculline produced a slight increase in the number of CRexpressing cells and a dramatic increase in the number of SS-producing cells (213).
Application of the AMPA receptor blocker DNQX shifts the balance of inputs to favor
inhibition, and while it did not appreciably alter the number of CR-expressing cells, it did
cause a large drop in the number of cells containing SS (213). Assuming the same
phenomenon occurs in neocortex, increased excitation during development, then, has the
potential to lead to an increase in number of somatostatin-expressing cells.
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Furthermore, cluster analysis of gene expression has revealed a correlation
between the mRNA for three main classes of ion channel expression and the three
identified calcium-binding proteins (349). This indirectly strengthens the link between
specific cellular contents and particular electrophysiological properties, as ion channels
are responsible for the characteristics of action potential firing. For example,
interneurons expressing mRNA for CR also contain a cluster of genes for ion channels
that are associated with accommodation (349). The ion channels correlated with CB are
associated with bursting behavior (349). PV is present in cells with ion channels that are
appropriate for high frequency discharge (72; 349), and it also correlates with
interneurons demonstrating FS firing patterns (60). Although it is not possible to
unambiguously place each and every interneuron in a strictly defined group (209), the
connections between morphology, electrophysiology and molecular markers make it
possible to more clearly segregate the roles that may be shared by similar cells.

1.4.4 Interneuron connectivity and circuitry
The morphological and electrophysiological differences between interneuron
subtypes can be translated into functional differences as well. Subtypes of interneurons
may be able to perform particular roles by virtue of the fact that they target specific
domains on an excitatory cell (175; 209; 324). Interneurons that send synapses to the
soma affect the local generation of sodium dependent action potentials, while those that
synapse on distal dendrites may modulate calcium-dependent action potentials (217;
225). Interneurons that synapse on dendrites are more suited to have a modulatory role in
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general, due to their distance from the soma, while cells synapsing on or near the cell
body can effect stronger inhibition. A particularly good example is the chandelier cell;
synapsing selectively on the axon initial segment of pyramidal cells, it provides the final
inhibitory control before the action potential is allowed to propagate down the axon
(323). Interneurons with different electrophysiological properties can also elicit
postsynaptic responses that can be differentiated from each other. For example, IPSCs
recorded in pyramidal cells are typically larger when produced by FS cells than when
they are produced by LTS cells (369).
GABAergic neurons also create synapses with various classes of other inhibitory
cells (141; 324) and, through autapses, themselves (324). This connectivity is determined
by morphology and cell type; while some are highly connected, others are not. For
example, there are no chandelier cell-chandelier cell connections (337). Basket cells can
synaptically target double bouquet cells, but more frequently, they target other basket
cells (337). Paired recordings have demonstrated that functional chemical synapses exist
between FS and LTS cells, although of the various possible synaptic combinations, there
is the least LTS to LTS cell inhibition (131). Electrical coupling through gap junctions
occurs in neocortex as well, connecting one interneuron to others of the same
electrophysiological type (125).
With regard to the excitation of interneurons, the GABAergic cells receive
glutamatergic input for one of two purposes: (1) to produce feed-forward inhibition in
response to direct excitation, or (2) to complete a feedback mechanism, usually initiated
by axon collaterals from principal cells. The EPSCs recorded from interneurons are
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faster than the corresponding events in pyramidal cells (51; 128; 149). Interneurons with
basket cell morphology and somatic targets tend to receive fewer synapses from a single
pyramidal cell than dendrite-targeting or bipolar interneurons (51). However,
thalamocortical input to GABAergic cells preferentially innervates FS over LTS
interneurons in neocortex (131). Additionally, it has been shown that thalamocortical
fibers produce EPSPs that have larger amplitudes and are more reliable in FS cells than in
nearby spiny cells (330).
Target-cell-specific modification of excitatory input has also been shown to differ
between interneuron subclasses. Generally, paired pulse depression occurs in
interneurons that target perisomatic domains, but paired pulse facilitation is observed in
dendrite-targeting interneurons (276). Confirming this, in bitufted cells that express
somatostatin, facilitating eEPSCs are elicited. Multipolar cells with parvalbumin
immunoreactivity demonstrate a depressive response (276). Also, when postsynaptic
responses are recorded from different interneurons innervated by the same pyramidal cell,
facilitation and depression are both observed, suggesting that the differential effect on
eEPSPs is due to factors unique to each synapse, dependent on the postsynaptic
interneuron subtype (276; 360). Furthermore, a single interneuron produces the same
characteristic response (either facilitating or depressive) when stimulated by several
different pyramidal cells, although each of them may have a different time course (210).
The cellular location of excitatory afferents may play a role in this temporal disparity.
Chemical synapses between interneurons allow the formation of circuits, but
more specialized networks are formed when certain interneuron subtypes are joined
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through electrical connections. Dye coupling has been observed between interneurons in
hippocampus (224) and in neocortex (78), indicating that these cells are contiguous.
Coupling occurs at a greater frequency and for a larger number of interconnected neurons
in juvenile cortex (two weeks postnatal) than for adult cortex (78; 253). Specifically, gap
junctions between PV immunopositive interneurons with FS characteristics have been
described in neocortex (79; 122; 131), and electrical connections between SS-containing
LTS cells have also been demonstrated (79; 87; 131). Synchronous responses in pairs of
LTS cells following the application of a metabotropic glutamate receptor agonist have
been shown to depend on electrical coupling (27). Molecular work and
immunohistochemical studies have supported the presence of a gap junction protein
nearly specific for neural tissue, Cx36 (76; 83; 272). Cx36 is sparsely expressed in adult
rat cortex but has a fairly global presence in neurons of the early postnatal cortex, as
measured by both immunohistochemistry and in situ hybridization (29; 30). Both PV and
SS-expressing interneurons can be identified by a β-gal reporter activated by the Cx36
promoter, indicating that Cx36 is likely responsible for the electrical connections in both
types of interneuron (87). Knock-out mice that lack Cx36 have shown a loss of electrical
communication between inhibitory cells in cortex, as well as a severe impairment in LTSdriven oscillatory activity (87). While FS and LTS cells do inhibit each other through
synaptic contacts they are virtually never electrically connected to each other (131).
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1.4.5 Modulation of activity
Neuromodulatory transmitters provoke a variety of responses in interneurons
based on cell type. Acetylcholine, for example, hyperpolarizes FS cells but excites LTS
cells in rat visual cortex (368), providing a mechanism for differential control of
interneuron subpopulations. Dopamine differentially modulates inhibitory transmission
from separate interneuron subtypes as well (126; 351). Norepinephrine and serotonin
have heterogeneous effects on interneurons (14). There is also evidence that specific
interneuron subpopulations are selectively targeted by serotonergic afferent inputs (106;
249).
Interneurons have the capability to modulate their own activity as well.
Neocortical FS cells use GABAergic autaptic (self-synapsing) transmission, which is
largely responsible for the precision of the action potential train they are able to fire in
response to an injected depolarizing pulse (12). By virtue of the fact that FS cells
synapse on themselves and other FS interneurons, simultaneous autaptic and synaptic
inhibition could contribute to synchronous activity within a population of these cells.
Experiments blocking autaptic transmission with gabazine increased the variability of
spike firing in FS cells, while simulating autaptic transmission on pyramidal cells
resulted in increased precision of action potential firing (12). Corroborating this with
morphology, immunohistochemical data shows that both basket cells and dendritetargeting cells form numerous autapses (336); however, double bouquet cells do not form
as many (324). Bacci et al. demonstrated that LTS cells in neocortex generally do not
provide self-inhibition via autaptic connections, but they can modulate their own activity
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by producing endocannabinoids that function in an autocrine manner (13). This has been
referred to as a slow self-inhibition in which the experimental application of multiple
trains of action potentials results in a prolonged hyperpolarization of the membrane
potential. This long-lasting effect specific to LTS cells is similar to a subtype-specific
long term depression (13).

1.5 Development of interneurons
In order for the cellular components of the neocortex to perform their correct
functions, proper development must ensure the correct lamination and connections.
Disruption of this process produces the malformations described earlier in this chapter.
The following sections discuss our current understanding of interneuron development and
migration in normal cortex, a process that has some differences compared to pyramidal
cell migration. Cortical excitatory neurons are generated in the ventricular zone and form
the preplate, the platform for the developing neocortex. When neurons divide and exit
the cell cycle to differentiate, they split the preplate into two parts, the subplate (near the
ventricle) and the marginal zone (close to the pial surface). A scaffolding of radial glia
guides migrating pyramidal neurons to their proper layer, determined by neuronal birth
date. Cortical GABAergic neurons, on the other hand, originate in one of several
interneuron progenitor regions in the subpallial telencephalon and migrate tangentially to
the cortex (112).
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1.5.1 Neurogenesis, migration, maturation
The medial, lateral, and caudal ganglionic eminences (MGE, LGE, CGE) of the
developing basal ganglia are the source of cortical interneurons in rodents (6; 237; 363).
The formation of different subtypes of interneurons from these sources may be due to
separate pools of progenitors, factors present in the cortex during their time of migration,
or a combination of both of these (54; 112). The MGE appears to be the source of cells
expressing somatostatin and parvalbumin, but not calretinin (370). In vivo studies in
mice that lacked the regionalization-regulating transcription factor Nkx2.1 revealed a
very poorly developed MGE, and only fifty percent of expected GABAergic cell
population was present by E18.5 (332). In this model, there was almost a complete lack
of cells immunopositive for somatostatin (6). In conjunction with this,
electrophysiological studies of MGE and CGE-derived interneurons also reveal two main
cell types. Recordings from MGE-derived cells indicate that the predominant mature
interneuron type formed is the FS cell (54). This parallels the finding that parvalbumin
positive cells derive from the MGE precursor population (370). The second most
populous type had firing characteristics similar to LTS cells, which is consistent with the
firing patterns of cells described previously to contain somatostatin (54; 60). In the
mouse, cells that originate in the MGE migrate through the neocortical SVZ in order to
populate the neocortex with a large proportion of its inhibitory cells (363). Although
cells from the LGE were originally thought to populate the cortex as well, they generally
remain in the basal forebrain and migrate to the olfactory bulb (363). CGE-derived cells
migrate to layer V of the neocortex but also to hippocampus and several basal ganglia

36
structures (237; 363). While cells from the MGE appear to migrate laterally and spread
widely, CGE-derived cells travel more specifically toward the caudal end of the
telencephalon, and they do it more rapidly than cells from the MGE (223).

1.5.2 Cortical organization and lamination
Cortical organization is complex, including layer-specific targets and outputs as
well as local circuitry, and it is important that inhibitory cells migrate to the appropriate
position within the neocortex. Interneurons follow the same inside-out developmental
pattern used by neocortical projection cells (7; 354). The reelin pathway is a crucial
signaling pathway for the proper development of lamination by projection neurons, and it
has recently been implicated in the laminar distribution of interneurons as well. Studies
in Reelin and Dab-deficient mice demonstrate that early-born interneurons in animals
lacking this signaling pathway (E12.5-13.5) have a pattern of layer inversion, but lateborn cells (E15.5-16.5) are randomly dispersed throughout the entire cortex (143). To
investigate whether this was actually due to a deficit in reelin signaling or if the cause
was simply an insufficiency in local cues caused by the distorted arrangement of
projection cells, a p35 mutant displaying aberrant cortical structure but intact Reelin was
used. In this case, the late-born interneurons found their proper destination (143). It is
possible, then, that the early-born cells may rely more on environmental cues from other
cellular elements for their proper lamination, while late-born interneurons depend heavily
on reelin signaling. Interestingly, late-born interneurons transplanted into younger tissue
are able to adopt the fates expected for early-born interneurons, and the converse is also
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true (354). This suggests that while the birth date of interneurons is a key determinant for
ultimate laminar identity, the migrating cells also rely on extracellular cues to find their
place in the developing neocortex. In the freeze-lesion model, the combination of
ischemia and cell death may affect these cues and, as a result, interneuron migration. In
fact, Reelin deficiency has a demonstrated association with the development of
microgyric lesions (277). Disrupted organization of Reelin-secreting Cajal-Retzius cells
was also observed within this malformation. These observations were made in a
transgenic mouse overexpressing brain-derived neurotrophic factor (BDNF), which
appears to downregulate the expression of Reelin (277). This is interesting in light of the
fact that the presence of Cajal-Retzius cells is actually prolonged in the freeze-lesion
model (331). The presence of persistent reelin-positive cells resembling Cajal-Retzius
cells has also been observed in a number of patients with polymicrogyria (103). If excess
BDNF affects both Reelin and Cajal-Retzius cells, perhaps some abnormality in this
neurotrophic factor contributes to their extended presence in PMG cortex.
Interneurons also exhibit a type of movement called ‘ventricle-directed
migration.’ GABAergic cells generated in the ganglionic eminences migrate tangentially
toward the ventricular zone, where excitatory cells are undergoing neurogenesis. At that
point they stop, then continue in a radially directed manner toward their final destination
in the neocortex (223; 235). BrdU labeling studies have shown that cells immunopositive
for GABA are post-mitotic when they are present in the ventricular zone, indicating that
they are not being generated in that location (243). Perhaps this migratory route through
the ventricular zone provides the interneurons with signaling information to facilitate the
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integration of these cells into cortical layers in a manner that is coherent with their
isochronic excitatory counterparts.

1.6 Summary and hypothesis
Hyperexcitability in malformed, epileptogenic cortex is a complicated
phenomenon that likely requires the contribution of several cortical components. At this
point, it is known that epileptiform activity can be evoked from the freeze-lesioned cortex
beginning abruptly at P12 (157), but increased functional excitatory input to pyramidal
cells develops gradually during the preceding week of postnatal development (375). The
delay prior to the expression of hyperexcitability suggests that developmental processes
may “mask” the effect of increased excitation until the end of the second postnatal week.
Of the other cell types in neocortex that may play a role in this, interneurons are an
attractive target for several reasons. During the first two postnatal weeks, these cells are
in the process of maturing with regard to the action of GABA (278), expression of
calcium binding proteins (4) and firing pattern (214). As persistent immature
characteristics are observed in this model (290), one possibility is that the normal
development of interneurons is delayed. By the second postnatal week, insufficient
inhibitory control may simply permit excitation to dominate. However, inhibitory
function appears to keep excitation in check until that time. Furthermore, there is indirect
evidence of increased excitatory input to inhibitory cells in this model (160). A second
possibility, and the one addressed by this study, is that the interneuron population is
altered during development in a way that actively contributes to hyperexcitability.
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Evidence of interneuron alteration has been demonstrated in experimental
paradigms of hyperexcitability and epilepsy, including the freeze-lesion model. In
addition, immunohistochemical studies support the concept that this effect can be
subtype-specific (49; 93). Rosen et al. have demonstrated a selective decrease in PV
immunostained cells in PMG cortex (288). There is a corresponding decrease in the
number of cells expressing PV in human tissue removed from patients with intractable
temporal lobe epilepsy (91). However, contrasting evidence from a separate study shows
no change in the number of PV cells in PMG cortex (308). One possible reason for this
discrepancy is that while Schwarz et al. counted cells within columns spanning the entire
distance from pia to white matter, Rosen et al. considered the superficial and deep layers
as separate populations. By separating the populations, the authors revealed an
infragranular -specific decrease in the PV-expressing interneuron population (288).
Partially for this reason, layer V was chosen for the studies reported here. A transient
decrease in PV expression was also observed in supragranular layers that resolved after
P21 (288). Comparatively, at the time that epileptiform activity can first be evoked in the
freeze lesion model (P12), there appears to be no change in the number or density of the
subset of interneurons expressing SS in PMG cortex (250). The experiments described in
the following chapters investigate whether this type of selective alteration is also
observed with regard to the intrinsic properties and/or functional connectivity of
interneurons.
The general hypothesis of this study is that interneuron populations in the freezelesion model are differentially affected in a pro-epileptogenic manner. More specifically,
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these experiments are based on the premise that increased vertical inhibition, due to
alterations in the LTS population, could promote columnar synchrony; while decreased
horizontal inhibition, due to alterations in the FS population, could lead to the spread of
this synchronous activity to neighboring columns. Prior to making statements about the
network activity of these interneuron populations, however, it is important to understand
the properties of each subtype in order to determine what pertinent changes occur at the
cellular level. Therefore, the three main questions addressed by the work presented in
this dissertation are:
(1) Is interneuron subtype identity maintained in lesioned cortex, and are the intrinsic
properties of these subtypes differentially affected by this developmental insult?
(2) Is the excitatory synaptic input to interneuron subtypes differentially altered in
malformed, epileptogenic cortex?
(3) Is the inhibition mediated by vertically-oriented LTS cells increased in lesioned
cortex?

Chapter 2
Altered Intrinsic Properties of Neuronal Subtypes in Malformed, Epileptogenic
Cortex

Introduction
Neuronal output is shaped by intrinsic properties that influence the reliability and
pattern of action potential firing in response to synaptic input (25; 33; 180). These
properties are secondary to the complement of ion channels located in the neuronal
membrane, as well as the currents that pass through them (25; 164; 372). Increasingly,
CNS disorders such as epilepsy are being linked to aberrant ion channel expression and
the corresponding current alterations (35; 56; 165). In particular, this has been
demonstrated in pediatric epilepsy related to cortical dysplasia (64; 215). Although the
mechanisms that underlie epilepsy are not fully known, it is likely that changes to both
neuronal intrinsic properties and synaptic connectivity play a role (53; 270). In fact,
when modeling epilepsy in a paradigm that does not include disinhibition, alteration of
intrinsic properties is necessary for the development of epileptiform activity (53).
Specifically, the creation or enhancement of a neuron’s capacity to generate bursts of
action potentials promotes the development of hyperexcitability (65; 267; 296; 361).
Alterations to the intrinsic cellular properties that appear to play a role in the
pathology of hyperexcitability have been demonstrated in various animal models. For
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example, in the TISH rat that mimics subcortical band heterotopia, pyramidal cells
identified by morphology and firing pattern had resting potentials that were more
depolarized than those in control cells (352). In a model of post-traumatic cortical
hyperexcitability, pyramidal cells demonstrate higher input resistance, a longer time
constant and a steeper f-I slope than control (270). Also, in the methylazoxymethanol
(MAM) model of cortical dysplasia and heterotopia, some pyramidal cells exhibited
smaller peak amplitudes, higher input resistance, longer action potential duration, less
adaptation and higher firing frequency than control (56). Abnormal potassium channel
expression in hippocampus (56) and excessive bursting behavior in neocortex (297) were
also observed. In the freeze-lesion model used for the present study, pyramidal cells in
layer II/III have altered intrinsic properties, such as decreased spike amplitude, maximum
rate of spike rise, dV/dt ratio and primary F-I slope (201). These characteristics reflect
delayed maturation, which has emerged as a theme in this model (142; 290; 331) and is
also characteristic of human cortical dysplasia (62). For the purpose of comparison with
the layer II/III results, but also because epileptiform activity likely originates in layer V
(341), the focus of this work will be on layer V(342). In the freeze-lesioned cortex,
excitatory synaptic input to layer V pyramidal cells gradually increases during the second
postnatal week (375), but epileptiform activity cannot be evoked until postnatal day (P)12
(157). It is possible that until P12, concurrent developmental processes in the inhibitory
cell population are sufficient to dampen the effect of increased excitation. Normally, by
the end of the second postnatal week, a number of properties of both inhibitory and
excitatory neurons approach mature values (4; 118; 214; 220; 278). If maturation of
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intrinsic properties is delayed or otherwise altered in either population, it may be
sufficient to “unmask” the synaptic changes. Therefore, we have chosen to investigate
the intrinsic properties not only of pyramidal cells, but also interneurons of layer V in
lesioned cortex.
Interneurons exhibit a multiplicity of properties that have been used to categorize
them into a number of distinct groups (60; 61; 170; 173). The morphological variety of
inhibitory cell types suggests that there is normally an anatomical division of labor
among the interneurons of the cortex (209). Previous epilepsy studies suggest that
interneuron subtypes can be selectively affected in both animal model and human patient
tissue (49; 91; 288). For this reason, it is necessary to compare not only excitatory and
inhibitory cell types, but also interneuron subtypes individually. In particular, fastspiking (FS) and low-threshold-spiking (LTS) interneurons have been well-described and
differ significantly on a number of intrinsic characteristics (28; 131; 169; 173). FS
interneurons are immunopositive for PV (60; 170), have basket cell or chandelier cell
morphology (170; 172), receive powerful thalamocortical input and synaptically target
cell bodies and thick dendrites (175). In FS cells, action potential half-width is typically
less than 1 ms and there is little to no adaptation in the characteristically high action
potential firing frequency (60; 173). In contrast, LTS interneurons have an action
potential half-width slightly greater than 1 ms and an action potential firing pattern that
shows clear adaptation (173). LTS interneurons are often immunopositive for SS (60;
170), have bipolar or bitufted morphology (170; 172), receive little input from thalamus,
and synaptically target thin dendrites distant from the soma (175).
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Here we have examined the intrinsic properties of layer V pyramidal cells and
two subtypes of interneurons to determine: (1) whether subtype identity is maintained in
malformed cortex; (2) if the focal loss of deep layers during the last stages of neuroblast
migration into the cortical plate can alter intrinsic properties; and (3) whether neuronal
subtypes are differentially affected by this developmental insult.

Materials and Methods

Freeze lesion surgery
Freeze lesions were made as described previously (375). Rat pups aged postnatal
day (P)1 were anesthetized with hypothermia by placing them in ice for 4-6 minutes, and
an anterior-posterior incision was then made in the scalp. The freeze probe, consisting of
a copper bar with a 2x5 mm rectangular tip cooled to -50◦C, was applied to the exposed
skull over the somatosensory cortex of the left hemisphere for 5 seconds. The skin was
sutured, the pup warmed and returned to the dam.

In vitro slice preparation and electrophysiology
Lesioned animals and unoperated control rats aged P12-17 were anesthetized with
isoflurane and decapitated. The brain was quickly removed and immediately placed into
cold (4◦C) sucrose slicing solution containing (in mM): 2.5 KCl, 1.25 NaH2PO4, 10
MgCl2, 0.5 CaCl2, 26 NaHCO3, 11 glucose and 234 sucrose. For interneuron recordings,
coronal sections 300 µm thick were made and transferred to a holding chamber filled
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with artificial cerebrospinal fluid (aCSF) containing (in mM): 126 NaCl, 3 KCl, 1.25
NaH2PO4, 2 MgCl2, 2 CaCl2, 26 NaHCO3, and 10 glucose. In attempts to select and
record from various interneuron subtypes, the inclusion of some pyramidal neurons in the
group of recorded cells is inevitable. As an aid to determine which cells were pyramidal,
we have included here, for comparison, the intrinsic properties of pyramidal neurons
recorded in a separate study. The focus in that separate study was to isolate layer V
pyramidal neurons from other laminar influences, and therefore, the slices were cut
horizontally (300 µm) through layer V. Neurons in the control horizontal slices had
intrinsic properties similar to those previously reported for layer V pyramidal neurons in
coronal slices (201). After sectioning, slices were transferred to a holding chamber filled
with artificial cerebrospinal fluid (aCSF) containing (in mM): 126 NaCl, 5 KCl, 1.25
NaH2PO4, 2 MgCl2, 2 CaCl2, 26 NaHCO3, and 10 glucose. For these cells, recordings
were made in normal aCSF containing dinitroquinoxaline [(6,7)],2,3(1H,4H)-dione
(DNQX, 20 µM) and D,L-2-amino-5-phosphonopentanoic acid (APV, 100 µM) to block
AMPA and NMDA receptors, respectively. Sections were maintained at 34◦C for 45
minutes and at room temperature thereafter. All solutions were infused with
95%O2/5%CO2, maintaining pH at 7.4. Recordings were made in aCSF at 30-32◦C,
osmolarity was adjusted to ~290 mOsm.
The whole-cell patch clamp technique was used to record from layer V
interneurons and pyramidal cells in somatosensory cortex from both control and
malformed cortex. Prior to recording, access resistance (Ra) was measured, and only
those cells with Ra less than 23MΩ were used for analysis. Recordings were terminated
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if access resistance increased more than 20% or if there was any evidence of declining
cell health. The cortical area used for recording was 0.5-1.5 mm on either side of the
lesion and from homotopic cortex in controls. Interneurons were selected based on
morphological criteria identified under DIC optics: absence of the apical and basal
dendrites and smaller soma than the typical layer V pyramidal cell. These recordings
specifically targeted LTS and FS cells. LTS cells were identified by their spindle-shaped
appearance and large processes extending towards both the pial surface and subcortical
white matter. FS cells had smaller somata with thinner processes in a multipolar
distribution. Pyramidal cells were identified by their relatively larger somata and
prominent apical dendrites. The intracellular solution used for interneuron recordings
contained (in mM): 130 K-gluconate, 10 Hepes, 11 EGTA, 2 MgCl2, 2 CaCl2, 4 Na-ATP,
and 0.2 Na-GTP. Patch solution for pyramidal cell recordings in horizontal slices
contained (in mM): 70 K-gluconate, 70 KCl, 10 Hepes, 4 EGTA, 2 NaCl, 4 Na-ATP, 0.3
Na-GTP. Osmolarity and pH of the intracellular solution were adjusted to 275-285
mOsm and pH 7.3. In some cases biocytin (0.05-0.2%) was included in the pipette in
order to identify neuronal morphology with subsequent staining. Biocytin-filled cells
were visualized using fluorescein-conjugated streptavidin (10 µg/mL, Molecular Probes).
Recordings in current clamp were made using a Multiclamp 700A (Axon
Instruments) and digitized with a Digidata 1320A and pClamp software (Axon
Instruments, at 20 kHz). The resulting files were analyzed using Clampfit (Axon
Instruments) and Minianalysis (Synaptosoft) software.
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Intrinsic property measurements
Each cell was injected with a series of hyperpolarizing and depolarizing square
pulse currents, 400 ms in duration. Current was delivered at an initial level of -40 nA,
then increased by steps of 20, 30, or 40 nA to the point where the cell fired at a maximal
rate. From these recordings, a number of intrinsic properties were calculated for both
pyramidal cells and interneurons. Adaptation was calculated three ways. Total
adaptation was calculated by dividing the frequency of the last two action potentials by
the frequency of the first two. Early adaptation was calculated as the ratio of the
frequency of action potential firing at 200 msec to the frequency of the first pair of action
potentials. Late adaptation was calculated as the ratio of the frequency of the last pair of
action potentials and the fourth pair. A ratio of one represents no adaptation, while
increased adaptation is reflected by an increasingly smaller number. Other measures
included action potential half-width, percent increase in half-width from the first to
second action potential, peak of first and second afterhyperpolarizations (amplitude
measured relative to the threshold for action potential firing), time to peak for the first
AHP (relative to the first action potential peak), accommodative hump (the difference
between the peak of the smallest action potential and the peak of the subsequent largest
action potential), minimal discharge frequency and time of minimal discharge. Action
potential amplitude, maximum rates of rise and decay, dV/dt ratio and primary F/I slope
were also calculated as described previously (201). Briefly, the amplitude and the max
rise and decay rates were determined for the initial action potential in the first sweep with
a suprathreshold current. Primary F/I slope was determined from a plot of the frequency
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of the first two action potentials (Hz) versus the magnitude of injected current (nA). ttests were used to compare control vs. PMG for each group, p <0.05 was considered to be
significant.

Immunohistochemistry
Rats aged P13-14 were anesthetized with isoflurane and transcardially perfused
with 4% paraformaldehyde. The rats were decapitated, each brain removed and stored in
paraformaldehyde at 4°ºC overnight. Parasagittal sections 80 µm thick were made from
the left hemisphere of both lesioned animals and un-operated controls. Simultaneous
triple immunohistochemical staining was performed for SS (rabbit anti-SS, 1:1000,
Peninsula Labs; AlexaFluor 568 goat anti-rabbit, 1:100), PV (mouse anti-PV, 1:5000,
Sigma; AlexaFluor 405 goat anti-mouse, 1:100) and vasoactive intestinal peptide (VIP,
guinea pig anti-VIP, 1:1000, Peninsula Labs; Fluorescein goat anti-guinea pig, 1:200).
Sections were incubated in primary antibody solution for SS, PV and VIP on the shaker
overnight at room temperature (10%NGS, 2%BSA, 0.5%TritonX-100/TBS). Sections
were washed in TBS, incubated in secondary antibody solution for three hours on the
shaker at room temperature (10%NGS, 2%BSA, 0.5%TritonX-100). Sections were
mounted on unsubbed slides and coverslipped with Prolong Anti-fade mounting medium.
Images were obtained using a Leica TCS-SP2 AOBS confocal laser scanning microscope
at the Virginia Commonwealth University Department of Anatomy and Neurobiology
Microscopy Facility.

49
Results

Classification of cortical neuronal subtypes
Whole cell recordings were made in current clamp from neurons in layer V of
control and PMG cortex. Cells were depolarized with a series of currents (400 ms
duration step pulse), eliciting low and high frequency trains of action potentials (Fig.
2.1). Within PMG cortex, we observed a range of neuronal action potential firing
patterns that was similar to what was seen in control cortex. A number of previously
published studies have used these characteristic patterns to identify interneuron subtypes
(13; 15; 27; 28; 131; 169; 170; 367). Based on firing patterns, the recorded cells were
placed into one of three groups; pyramidal neurons (Fig. 2.1A,B), FS interneurons (Fig.
2.1C), or LTS interneurons (Fig. 2.1D). Some neurons that were initially selected as
potential interneurons based on the DIC image prior to recording showed firing patterns
similar to pyramidal cells, so we have called these “suspected pyramidal cells” (Fig.
2.1B). To help classify these cells, the firing patterns from pyramidal cells identified in a
separate study were used here for comparison (Fig. 2.1A).
A quantitative confirmation of this pattern-based group assignment is shown in
figure 2, where total adaptation is plotted against the amplitude of the first AHP minus
the amplitude of the last AHP for individual cells (AHP difference). Adaptation of action
potential firing frequency is commonly used to distinguish LTS from FS interneurons
(28; 169). AHP difference has also been shown to reliably distinguish pyramidal cells
from LTS interneurons (28). In order to confirm that this measure could be used in our

50
data to separate LTS cells from the pyramidal cells mistakenly recorded while looking for
interneurons, we included the previously identified pyramidal cells in this plot as well.
This graph shows a clear demarcation between three neuronal cell types (pyramidal, FS,
LTS) for both control and PMG populations (Fig. 2.2). Using this methodology, several
cells were not classified as FS, LTS, or pyramidal cells. The AHP difference indicated
that these cells were unlikely to be pyramidal, but their adaptation ratio did not clearly
align them with one of the two interneuron subpopulations. It is likely that these cells
represent one or more additional subtypes of interneurons that are beyond the scope of
this study. Additionally, the “suspected pyramidal cells” clearly segregated with the
group of known pyramidal cells (Fig. 2.2).

Intrinsic properties of cortical neuronal subtypes
A number of intrinsic properties have been useful in differentiating interneuron
subtypes (60; 61; 169; 172). Here we have made the same measurements as Cauli et al
(60; 61), as they had the most extensive list of properties that clearly separated cell types.
This analysis allows us to determine if the intrinsic properties that differentiate
interneuron subtypes are altered in PMG cortex. It also confirms whether each action
potential firing pattern correlates with a specific array of intrinsic properties in PMG
cortex as it does in control. For control cells, our values were very similar to those
reported by Cauli et al in most cases, including first and second action potential duration,
percent increase in action potential duration, first and second afterhyperpolarization
amplitudes, and relative values for early adaptation ratio (Table 2.1). Our LTS cells were
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similar to their RSNP-SS interneurons. There were some dissimilarities between our
values and Cauli’s for accommodative hump, minimal firing frequency and time of
minimal firing frequency. All of these discrepancies are likely due to the difference in
the length of our depolarizing step (400 msec) compared to theirs (800 msec). In
addition, we did not restrict our calculation of minimal frequency to sweeps that began
with frequencies of 100 Hz or more. However, even with these differences, minimal
firing frequency showed the same relative differences between FS and LTS cell
populations in our data (LTS significantly lower than FS, Table 2.1) as FS and RSNP-SS
did in Cauli’s. The other measures that distinguished FS and LTS interneurons within the
control group were the first and second action potential duration, percent increase in
action potential duration, AHP peak, early and late adaptation ratios, and accommodative
hump (Table 2.1, Fig. 2.3).

Pyramidal cell intrinsic properties
A previous study of layer II/III pyramidal neurons in freeze-lesioned microgyral
cortex found that cells in lesioned cortex exhibited slower action potentials compared to
control, suggesting delayed maturation of this intrinsic property (201). Similarly, we
found that in a train of action potentials, the half-width of the second action potential was
wider for layer V pyramidal neurons in PMG cortex compared to control (Fig.2.3). For
other measures, including maximum rate of rise or decay, or primary F/I slope, we found
no differences between control and PMG layer V pyramidal neurons (Table 2.2), in
contrast to previous findings in layer II/III.
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Interneuron subtype identity is maintained in malformed cortex
For a number of intrinsic properties, there was no difference between control and
PMG interneurons, including the first and second action potential duration, percent
increase in this duration, first and second AHP duration, early and late adaptation ratios,
accommodative hump, minimal frequency and time for minimal frequency (Table 2.1,
Fig. 2.3). The measures that distinguished FS and LTS interneuron subtypes in control
cortex also distinguished these subtypes in PMG cortex (Table 2.1). Some of these
parameters, including action potential half width and AHP amplitude have repeatedly
been used to distinguish these two subtypes in normal neocortex (60; 61; 169; 265).
The intracellular content of interneurons provides an additional basis for subtype
identification. Molecular markers PV, SS, calbindin (CB), calretinin (CR) and VIP are
each found within selective subpopulations of interneurons (173; 174; 184). These
identifiers are often correlated with particular morphologies and electrophysiological
characteristics (61; 173). One helpful feature of these markers for distinguishing
interneuron subtypes is that some of them are present in non-overlapping populations of
interneurons (PV, SS, VIP, 175). These markers are present early in development (152)
and therefore may be a useful tool to assess whether the path of neuronal differentiation
is altered during the formation of microgyria. Therefore, we addressed the specific
question of whether these markers were also found in non-overlapping populations in
PMG cortex. The quantitative assessment of the numbers of neurons has previously been
done for both PV (288) and SS (250) and is beyond the scope of this analysis, since we
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are concerned here with interneuron identity rather than number. High power z-stack
images show that no cells contained more than one of the immunohistochemical labels in
either control or PMG cortex (Fig. 2.4H,L,P,T). This finding was confirmed by
examining twelve separate fields in each of two control and two freeze-lesioned brains.
In no case was an overlap of any of the three markers present within a single cell. High
power images in control cortex show that PV-stained cells had a rounded somata and
multipolar morphology typical of basket cells (Fig. 2.4E,I). In PMG cortex, the
morphology of PV cells is similar, although individual neurons are less heavily stained,
with less clear dendritic arbors. In both control and PMG cortex, SS-stained neurons had
ovoid somata typical of bipolar neurons (Fig. 2.4F,J,N,R). VIP neurons were less
prevalent, but no differences in morphology were evident between control and PMG
cortex.
Dendritic and axonal morphology can also be used to distinguish interneuron
subtypes. While not all cells recorded and filled with biocytin can be recovered in
subsequent processing, in this study dendritic and/or axonal morphology was clear in 40
control and 43 PMG neurons from coronal slices. Quantitative examination of this
morphology will be performed in a separate study. Here we have made the following
qualitative classification of cell morphologies: (1) pyramidal neurons having a clear
apical dendrite (large, single dendrite directed toward the pia); (2) bipolar neurons having
multiple dendrites and/or axons that project vertically, typically both towards the pia and
towards the white matter, and typically crossing into other laminae; and (3) basket
neurons that have a round field of dendritic projection (approximately equal vertical and
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horizontal distance of dendritic projection) within layer V. Clear examples of all of these
cell types were found in PMG cortex (Fig. 2.5). After classification of the morphological
type, this was compared to the electrophysiological type. In the majority of cases for
both control and PMG cortex, there was a match. In control cortex, 77% of
electrophysiologically-identified pyramidal neurons had a clear apical dendrite. The
same was true for 89% of PMG pyramidal neurons. In control cortex, 92% of LTS
neurons had a clear bipolar morphology, while this was true for 69% of PMG neurons. In
control cortex, 60% of FS cells had clear basket cell morphology, and this was true for
64% of PMG FS neurons. There were 2 cells in each of control and PMG cortex whose
morphology could not be clearly characterized.

Interneuron firing rate is altered in PMG cortex
Although many intrinsic properties are unchanged in PMG interneurons compared
to control, several characteristics were altered that may affect inhibitory tone in
malformed cortex. Interestingly, these characteristics were differentially altered for LTS
and FS interneurons. In PMG cortex, the maximum firing frequency is decreased for FS
interneurons compared to control FS cells (Fig. 2.6A,C). In contrast, PMG LTS
interneurons have an increased maximum frequency compared to control LTS cells (Fig.
2.6B,C). These respective changes result in maximum firing frequencies for LTS and FS
interneurons that are not different from each other in PMG cortex, while this measure is
significantly different for the two interneurons subtypes in control cortex. The increase
in firing frequency for LTS interneurons may be due, in part, to the decreased duration of
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the first AHP (Fig. 2.6D,F). In particular, the early action potentials fire at a faster rate in
PMG LTS cells than in control. Despite the faster initial firing, adaptation still occurs in
PMG LTS cells. The shorter AHP and higher frequency at the beginning of the train
contribute to the increase in total adaptation observed in PMG compared to control LTS
interneurons (Fig. 2.6E,G). LTS interneurons also had a slightly less negative resting
potential in PMG compared to control (Table 2.2). FS interneurons in PMG cortex fired
action potentials with slightly larger amplitudes than FS cells in control cortex (Table
2.2).

Discussion
Based on intrinsic properties, pyramidal, FS and LTS neuronal subtypes can
clearly be distinguished in control cortex (15; 61; 131). Here we have found that this still
holds true for malformed, epileptogenic cortex (Fig. 2.2B). Thus the identity of these
neuronal subtypes is not altered by a developmental insult in the late stages of cortical
migration. While unique cell types can still be distinguished, some intrinsic properties
are altered in the PMG. This includes a slowing of the second action potential in a train
for pyramidal cells, suggesting that this property is at an immature state. The changes
also included a decrease in the maximum firing frequency for FS, but an increase in this
rate for LTS interneurons. Both of these changes are unlikely to be explained by the
same alteration in, for instance, potassium channels. These results demonstrate that
neuronal subtypes are in fact differentially altered during the formation of a microgyrus
and the adjacent hyperexcitable region of neocortex. In addition, the changes in
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maximum firing rate suggest that the ratio of synaptic input from FS versus LTS
interneurons could be altered, with that from LTS increasing while that from FS
decreases. Whether this occurs in individual neurons and how it might contribute to
epileptiform activity requires further exploration.
Maintenance of interneuron subtypes in PMG suggests that differentiation
proceeds normally after the lesion is made, or that most mechanisms defining cell type
are complete in layer V prior to the lesion and are unaffected by it. This is consistent
with our current understanding of interneuron subtype determination. First, the cells that
will eventually populate the PMG cortex are already born when the lesion is induced
(291). Secondly, interneurons likely receive their subtype-instructive information at the
place of origin, rather than from signals during migration (364). The source of cortical
interneurons in rodents includes the medial (MGE), lateral and caudal ganglionic
eminences (6; 237; 363), with the MGE serving as the major point of origin for cells
expressing somatostatin and parvalbumin (370). Parallel electrophysiological findings
indicate that the two predominant mature interneuron types formed from the MGE exhibit
firing characteristics of FS and LTS cells (54). In the MGE, prenatally active
transcription factors are important for determining the eventual interneuron fate,
identified by the expression of PV and SS (6; 97; 332).
It is clear from our data that selective intrinsic properties may be altered, leaving
others intact. Previously, an altered number of PV neurons in deep layers has been
demonstrated in PMG cortex (288), while the number of SS interneurons appears
unchanged (250). A selective change in particular interneuron subpopulations has been
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observed in other epilepsy models as well. Typically, it is the PV neurons that are
selectively decreased in neocortical models (266; 352), while SS-labeled neurons are
selectively reduced in some hippocampal temporal lobe models (47; 119; 328), as well as
in human temporal lobe epilepsy (239). The expression of PV in the rodent is not
observed with immunohistochemistry until the second postnatal week (4; 322), and may
be influenced by factors such as early activity (251), dopamine (264) and estrogen (292).
If the observed decrease in PV-stained neurons in the PMG (288) represents a
developmental alteration in protein expression, rather than simply the loss of some
GABAergic-PV cells, it is possible that incorrect protein expression or aberrant overlap
of several proteins within the same cell could occur. This would result in an altered
identity based on intracellular contents. Typically in epilepsy studies, changes in single
intracellular markers for interneurons have been studied without determining whether
there is any change in the co-localization of these markers. Here we have specifically
shown that the lack of co-localization of PV, SS and VIP in control tissue is maintained
in the PMG (Fig. 2.4), further suggesting that this aspect of interneuron subtype identity
is preserved.
In addition to the expression of calcium-binding proteins (152), dendritic
outgrowth (353) and some complex firing properties of interneurons (197) have reached
near-adult levels by the end of the second postnatal week. Firing properties and action
potential characteristics of pyramidal cells also approach mature values by the second and
third postnatal weeks (118; 220). Alterations in one or more of these properties during
development may contribute to the abnormal activity seen in epileptogenic cortex (25).
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This appears to be true in human dysplastic cortex, where the presence of dysmorphic,
immature cells indicate disruption of maturational processes (62; 64). For example,
cytomegalic neurons demonstrate abnormal membrane properties (64) and the ability to
generate calcium spikes with little provocation, possibly suggesting a role in epileptiform
activity (63). It is often difficult to discern whether intrinsic property alterations cause
the observed pathologies or occur in response to it, but neuronal alterations in disease
states tend to resemble non-homeostatic changes, rather than compensatory mechanisms
(25). Often these changes include mis-expression of channels or subunits that are
important for excitability or repolarization. For example, increased neuronal activity
(modeled with short term LTP induction or glutamate application) can cause altered
expression of voltage-gated potassium channels (179; 228), directly affecting cellular
excitability (228). A lack of functional Kv2.4 channels in heterotopic neurons of the
MAM model (56), as well as an upregulation of intrinsic bursting behavior following
pilocarpine-induction of status epilepticus (361) both create a tendency for
hyperexcitability. Interestingly, the type of alteration that occurs for a given channel or
type of current appears to depend both on the experimental model and the developmental
state of the animal. In immature rats (P10-11), hyperthermia-induced seizures resulted in
an enhanced Ih (71) that contributed to hyperexcitability, while kainate seizure induction
in more mature animals (five to six weeks) caused a decrease in Ih and the responsible
HCN channel subunits (312). Channel alterations likely underlie changes in firing mode
that have also been shown to promote epileptiform activity, including the development of
intrinsic bursting in layer V (296), increased bursting in CA1 following in utero treatment
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with MAM (17), and a transient suppression of AHP and increased firing frequency in
the kindling model (26). Selke et al. (311) have also demonstrated the dual loss of one
AHP component and adaptive firing behavior in hippocampal granule cells, causing
transient hyperexcitability in this population.

Pyramidal cell intrinsic property delayed maturation
A number of findings have contributed to the theme of delayed maturation
associated with malformation models (158). In the freeze lesion/PMG model, this
includes delayed expression of mature GABA subunits (89; 142) and chloride
transporters (316), as well as persistent radial glia (290) and Cajal-Retzius cells (331).
There is previous evidence of an immature state in pyramidal cell intrinsic properties
within layer II/III (201), and we find at least some similarities with an increased duration
of the action potential in the layer V pyramidal neurons recorded here (Fig. 2.3).
Typically, action potentials become shorter in duration and larger in amplitude by the end
of the second postnatal week (118; 220). Accompanying this change is a larger action
potential peak and a faster rate of rise and fall (220). Although we did not observe as
many changes in the pyramidal cell intrinsic properties, this may reflect the older age of
the animals at the time of recording in the previous study or a true difference between
laminae. In any case, both layers show an increased duration of the action potential
under some conditions. Prolonging the action potential could limit high frequency firing
or bursting, however, and may actually have an anti-epileptogenic effect in PMG (38).
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Differential alterations in interneuron subtypes
While the FS and LTS subtypes have maintained their identity in PMG cortex,
specific changes in their firing frequencies may represent altered efficacy for each cell
type, with interesting implications for interneuron function, as well as potential
underlying subcellular mechanisms. In particular, PMG LTS interneurons have an
increased maximum firing frequency (Fig. 2.6). One possible mechanism for increased
frequency is the elevated expression of voltage-gated potassium channels that permit
rapid re-polarization responsible for high-frequency firing. These channels normally
have a differential expression pattern in neuron subpopulations for both neocortex (68;
349) and hippocampus (46). The rapid action potential firing capabilities of FS cells may
rely, at least in part, on the expression of a specific potassium channel, Kv3.1 (72; 349).
Aberrant expression of channels like this could endow LTS cells with increased firing
capability. A decreased expression of this channel could contribute to retarding the speed
with which FS interneurons fire in the PMG. However, adaptive behavior typical of LTS
cells in normal cortex still occurs in PMG, and is actually increased due to a higher initial
firing frequency (Fig. 2.6).
Morphological properties associated with specific interneuron populations
indicate that tasks performed by each inhibitory population are likely assigned to a
specific subtype. LTS interneurons that are capable of firing at an increased rate could
create a more powerful inhibitory effect, perhaps augmenting their ability to synchronize
surrounding neurons. Even in the absence of excitatory synaptic input, networks of LTS
cells can exhibit synchronous, oscillatory behavior, resulting in synchronous IPSPs in

61
neighboring regular-spiking cells (27). Furthermore, inhibitory input to dendrites can
alter the phase of dendritic spiking (178), potentially synchronizing the probability and
timing of excitatory events in the dendrites that will ultimately influence cellular output.
Based on the vertical orientation and dendrite-targeting of the LTS cells (170; 172; 175),
this means that these cells may produced interlaminar, intracolumnar synchrony. At the
same time, the lower maximum firing frequency observed in FS interneurons could result
in a less powerful horizontal or intercolumnar inhibition. Both of these changes could
sway the balance of inhibition to allow the increased excitatory input (160) to contribute
to unregulated synchronous firing. It is yet to be determined whether or not increased
LTS firing is sufficient to synchronize cortical activity to the extent necessary to promote
epileptiform activity. This is currently being investigated through selective activation of
LTS interneurons.
Taken together, these data suggest that the differentiation of neuronal subtypes
proceeds relatively normally during reorganization of the cortex induced by focal loss of
deep layer neurons during the time of cortical migration. However, subtle changes in the
firing behavior of LTS and FS interneurons may supply enhanced interlaminar synchrony
and suppressed intercolumnar inhibition, ultimately contributing to hyperexcitability in
malformed cortex.
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Table 2.1 Intrinsic properties of layer V interneurons and pyramidal cells.
Electrophysiological
Parameter

FS

LTS

Pyr

Control (n=34)
PMG (n=30)

Control (n=33)
PMG (n=23)

Control (n=29)
PMG (n=22

1st spike duration, ms

0.77 ±0.04
0.81 ±0.06

§
§

1.08 ±0.05
1.03 ±0.05

1.86 ±0.08
2.03 ±0.12

2nd spike duration, ms

0.79 ±0.04
0.84 ±0.07

§
§

1.23 ±0.06
1.17 ±0.06

2.35 ±0.13
2.84 ±0.22**

Duration increase, %

2.8 ±0.6
2.7 ±1.0

§
§

13.4 ±1.4
12.6 ±1.7

25.8 ±4.4
39.6 ±6.9

1st spike AHP, mV

-11.8 ±0.6
-11.5 ±0.6

§
§

-8.6 ±0.6
-7.2 ±0.9

-3.9 ±0.7
-3.3 ±0.6

2nd spike AHP, mV

-14.9 ±0.6
-14.6 ±0.6

§
§

-11.2 ±0.6
-10.0 ±0.9

-14.0 ±0.8
-14.8 ±0.8

Early adaptation ratio

0.08 ±0.02
0.09 ±0.02

0.11 ±0.02
0.07 ±0.01

0.22 ±0.02
0.16 ±0.03

Late adaptation ratio

0.86 ±0.02
0.83 ±0.01

§
§

0.55 ±0.03
0.55 ±0.04

0.77 ±0.02
0.76 ±0.01

4.8 ±0.6
4.3 ±0.6

§
§

1.5 ±0.2
2.2 ±0.6

3.4 ±1.1
3.1 ±1.3

Minimal frequency, Hz

32.4 ±3.6
25.5 ±3.3

§
§

9.2 ±0.6
11.6 ±2.3

6.3 ±0.3
6.7 ±0.5

Time for min. freq., ms

188 ±21
171 ±17

201 ±14
170 ±16

175 ±9
176 ±12

Accommodative hump,
mV

Values are means ±SEM. n, number of cells; FS, fast-spiking cells; LTS, low-threshold spiking cells; Pyr,
pyramidal cells; Student’s t-test between control and PMG for each group, ** indicates p <0.05., Student’s ttest between FS and LTS in control and PMG populations, § indicates p <0.05.
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Table 2.2 Intrinsic properties of layer V interneurons and pyramidal cells.
FS

LTS

Pyr

Control
PMG

Control
PMG

Control
PMG

-62.7 ±6.3 (31)
-63.0±7.3 (24)

-55.4 ±4.2 (31)
-58.7±5.2 (19)**

-56.2 ±5.3 (28)
-57.3±8.2 (22)

Input resistance, MΩ

120 ±7 (32)
123 ±7 (25)

191 ±16 (32)
173 ±22 (21)

121 ±16 (29)
140 ±18 (21)

Spike amplitude, mV

81.8 ±1.1 (34)
85.3±1.3 (30)**

99.2 ±1.4 (33)
96.3 ±1.7 (23)

103.6 ±0.8 (28)
102.4 ±1.0 (16)

Max rate of rise, V/s

256 ±12 (34)
253 ±13 (30)

244 ±13 (33)
239 ±11 (23)

287 ±11 (28)
272 ±13 (16)

Max rate of decay, V/s

117 ±7 (34)
115 ±9 (30)

85 ±4 (33)
84 ±5 (23)

42 ±2 (28)
39 ±2 (16)

dV/dt ratio

2.3 ±0.1 (34)
2.4 ±0.1 (30)

2.9 ±0.1 (33)
2.9 ±0.1 (23)

6.9 ±0.2 (28)
7.1 ±0.3 (16)

Primary F/I slope (Hz/nA)

407 ±25 (34)
400 ±23 (30)

471 ±33 (33)
481 ±41 (23)

87 ±18 (28)
97 ±20 (16)

Electrophysiological
Parameter
Resting membrane
potential, mV

All data are expressed as means ±SE (n cells). Student’s t-test was used to compare control and PMG
values within each group, ** indicates p <0.05.

64

Figure 2.1 Example traces of neuronal responses to a series of current steps. Firing
patterns recorded in control (1,3) and PMG (2,4) cortex in response to depolarizing
current. Traces are shown for low frequency responses to small current steps (3,4) and
high frequency responses to larger steps in the same cells (1,2). These traces demonstrate
patterns typical for: A. Pyramidal cells identified in horizontal slices; B. Suspected
pyramidal cells recorded in coronal slices; C. FS; and D. LTS interneurons recorded in
coronal slices.
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Figure 2.2 Identification of neuronal subpopulations based on action potential
firing properties. The difference between first and last AHP amplitudes is plotted
against total adaptation ratio, which is the frequency of the first two action potentials
divided by the frequency of the last two action potentials. Each symbol shows the result
for a single cell. A. Control cells. B. PMG cells. Five cell types are represented: 1) FS =
fast-spiking; 2) LTS = low threshold-spiking; 3) pyramidal; 4) Suspected pyramidal
(initially expected to be interneurons but characterized as pyramidal cells based on action
potential characteristics); 5) unknown cell type (non-pyramidal, unclassified
interneurons).
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Figure 2.3 Comparison of action potential half-width in pyramidal, FS and LTS
cells. A. Example traces from pyramidal cells in control (1) and PMG (2). B. Enlarged
versions of the first (1) and second (2) action potentials from the traces shown above in
A, for control (gray, thicker line) and PMG (black, thinner line). C. Mean second action
potential half-width in control (gray) and PMG (black) for 29 and 22 pyramidal cells, 34
and 30 FS cells, and 33 and 23 LTS cells, respectively. * = t-test, p <0.05.
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Figure 2.4 Confocal images of parasagittal sections at low power (A-D) and high
power (E-T) showing immunohistochemistry to visualize parvalbumin (blue),
somatostatin (red), and vasoactive intestinal peptide (green). To prevent cross-talk
between channels, a sequential scanning procedure was used. Panel A, overlay of all
three fluorophores in control cortex. Panels B-D, overlay of all three fluorophores in
PMG cortex at locations within, near, and distant from the microgyrus, respectively.
Panels E-H, images of each fluorophore separately followed by overlay of the three
(same visual field) taken from layers II/III in control cortex. Panels I-L, images taken
from layer V in control cortex. Panels M-P, images taken from layer II/III in PMG
cortex. Panels Q-T, images taken from layer V in PMG cortex. For E-T, images are zstacks with a 1.5 µm slice. Scale bar in D for A-D = 200 µm, scale bar in T for E-T = 20
µm.
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Figure 2.5 Confocal images of individual cells that were recorded and later
visualized with fluorescein-conjugated biocytin. All cells are from PMG cortex and
are examples of A. bipolar, B. basket and C. pyramidal cell morphology. Scale bar = 10
µm.
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Figure 2.6 Altered action potential firing properties in neuronal subpopulations. A.
Example traces from FS cells in control (1) and PMG (2) demonstrating decreased
maximum firing frequency in PMG. B. Example traces from LTS cells in control (1)
and PMG (2) demonstrating increased maximum firing frequency in PMG. C. Maximum
firing frequency in pyramidal, FS and LTS cells. D. Example traces of initial action
potential firing from typical control (1) and PMG (2) LTS cells, showing decreased AHP
duration in PMG. E. Full trains of action potentials showing adaptation in control (1)
and PMG (2) LTS cells, increased in PMG. F. Duration of AHP. G. Average total
adaptation. Control (gray) and PMG (black) for 29 and 22 pyramidal cells, 34 and 30 FS
cells and 33 and 23 LTS cells, respectively. * = t-test, p <0.05.
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Chapter 3
Excitatory Synaptic Input to Interneurons is Differentially Affected in Malformed
Epileptogenic Cortex, Based on Subtype

Introduction
Many of the existing anti-epileptic drugs (AEDs) are ineffective when used alone
to treat seizures (187), especially for children who can attribute their seizures to cortical
malformations (263). Polymicrogyria, a developmental malformation involving the focal
loss of cortical deep layers, is associated with epilepsy and often causes intractable
seizures that require surgical intervention (186; 246; 318). Selecting a surgical site is
difficult; however, as the epileptogenic region of cortex extends beyond the anatomical
malformation in many of these patients (70; 137; 139). In addition, the underlying
mechanism responsible for hyperexcitability in polymicrogyria is not fully known.
In the freeze-lesion model of polymicrogyria, not only do the histological changes
in the rat mirror those of the human (99; 100) but an analogous electrophysiological
abnormality is also reliably demonstrated (156; 157; 202). About two weeks after the
lesion is made, epileptiform activity can be evoked consistently from the cortex
surrounding the lesion (156). Abnormal connectivity has been demonstrated, suggesting
that fibers that originally targeted the lesioned cortex have been redirected to the
surrounding paramicrogyral area, producing hyperinnervation with glutamatergic

76

77
afferents (159; 160; 286) . We have previously demonstrated a functional increase in
excitatory input to cortical PMG pyramidal cells prior to the onset of epileptiform activity
(375). The timing of this indicates that increased excitation alone does not account for
the abnormal activity, and a concomitant alteration of inhibitory cells may be necessary
to “unmask” the network hyperexcitability that is observed at P12. There is increased
excitatory input to at least some inhibitory postsynaptic targets as well (160), but
measures of overall inhibition do not demonstrate a clear change in this model (268;
269). Individual interneuron subtypes may be differentially affected by the aberrant
innervation in a way that is not obvious when inhibitory activity is examined as a whole.
This would mean that selective and specific connectivity, not random hyperinnervation,
is responsible for the generation of epileptiform activity.
Previous work has provided evidence of selective alterations that occur in both the
human condition and in epilepsy models. Evaluation of hippocampal tissue from patients
with temporal lobe epilepsy (279) and both the kainic acid (49) and kindling models
(321) revealed the presence of fewer somatostatin (SS)-immunopositive cells than
control. Also in the kainic acid model, a subset of parvalbumin (PV)-immunopositive
cells was selectively spared from injury (37). With regard to neocortex, a decrease in the
number of PV-immunopositive cells has been demonstrated in the TISH model,
accompanied by a lower frequency of sIPSCs (352). In the freeze-lesion model, Rosen et
al. have shown a selective decrease in the number of PV-immunopositive neurons in this
model (288; but see 308), while Schwarz et al. have demonstrated an increase in the
number of calbindin (CB)-stained cells (308). In contrast to the hippocampal studies, the
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number of interneurons containing SS appears to remain unchanged at the onset of
hyperexcitability (250). Some intrinsic properties of LTS and FS interneurons also
appear to be differentially altered in lesioned cortex (Chapter 2). In conjunction with
these results, is important to determine whether there are corresponding functional
alterations that occur in specific inhibitory cell populations.
The network of interneurons does not create a straightforward “off” switch, and
different interneuron subtypes have unique roles in neocortex (36; 209). For example, FS
interneurons that express PV have basket cell or chandelier cell morphology (170; 172).
Their axonal arbors have an intralaminar distribution that targets adjacent somata (175),
making them well-suited to deliver powerful inhibition and prevent the spread of
excitation to neighboring cortical columns. LTS interneurons that express SS have
bipolar morphology and a vertical bias (170; 172). These cells target distal dendrites for
synapse formation (175), and their distance from the site of action potential initiation
allows them to function in a modulatory capacity. Interestingly, there are situations in
which dendritic and somatic inhibition may be differentially altered. In the pilocarpine
model of temporal lobe epilepsy, for instance, a specific decrease in SS-immunopositive,
dendrite-targeting interneurons was observed in the hippocampus, paralleled by a
selective decrease in functional dendritic, but not somatic, inhibition of pyramidal cells
(80). The hypothesis addressed with the present study is that a similar phenomenon
occurs in PMG cortex, namely that dendrite-targeting LTS cells demonstrate increased
efficacy, while soma-targeting FS cells have less. These alterations would theoretically
leave overall inhibition intact while producing functional, pro-epileptogenic
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consequences specific to each cell type. For example, an increase in LTS/SS cell
function might increase columnar synchrony. An augmentation of this nature could be
achieved by increasing the excitatory input to LTS cells. In fact, this type of change was
noted in the pilocarpine model, where a greater number of action potential-driven events
was observed in the cells that provide somatic inhibition (80). In order to determine if
such a change occurs in PMG neocortex, excitatory postsynaptic potentials were recorded
from both FS and LTS interneurons.

Materials and Methods

Freeze lesion surgery
Freeze lesions were made as described previously (375). Rat pups aged P1 were
anesthetized by placing them in ice for 4-6 minutes. An incision was made to expose the
skull overlying somatosensory cortex of the left hemisphere. The freeze probe,
consisting of a copper bar with a 2x5 mm rectangular tip cooled to -50 ◦C, was applied to
the exposed skull for 5 seconds. The skin was sutured, the pup warmed and returned to
the dam.

In vitro slice preparation
Lesioned animals and unoperated control rats aged P12-17 were anesthetized with
isoflurane and decapitated. The brain was quickly removed and placed into cold (4◦C)
sucrose slicing solution containing (in mM): 2.5 KCl, 1.25 NaH2PO4, 10 MgCl2, 0.5
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CaCl2, 26NaHCO3, 11 glucose, and 234 sucrose. Coronal sections were cut at a thickness
of 300µm and transferred to a holding chamber filled with artificial cerebrospinal fluid
(aCSF) containing (in mM): 126 NaCl, 3 KCl, 1.25 NaH2PO4, 2 MgCl2, 2 CaCl2, 26
NaHCO3, and 10 glucose. Sections were maintained at 34◦C for 45 minutes and at room
temperature thereafter. All solutions were perfused with 95%O2/5%CO2, maintaining pH
at 7.4.

Electrophysiology
The whole-cell patch clamp technique was used to record spontaneous (s),
miniature (m) and evoked (e) excitatory postsynaptic currents (EPSCs) from layer V
interneurons in somatosensory cortex. Interneurons were differentiated from pyramidal
cells under DIC by their small, rounded or oblong somata and lack of clear apical or basal
dendrites. Recordings were made from an area of cortex 0.5-1.5 mm from the sulcus and
from homotopic cortex in controls. The intracellular solution used for recordings
contained (in mM): 130 K-gluconate, 10 Hepes, 11 EGTA, 2.0 MgCl2, 2.0 CaCl2, 4 NaATP, and 0.2 Na-GTP. With this solution ECl- = -71.5 mV. All voltage clamp recordings
were made at a holding potential of -70 mV, allowing excitatory events to be recorded in
isolation. The osmolarity and pH of the intracellular solution were adjusted to 275-285
mOsm and pH 7.3, respectively. Recordings were made in aCSF at 30-32◦C. For some
recordings, modified aCSF solution was used to increase the probability of
neurotransmitter release. This solution contained, (in mM): 126 NaCl, 3 KCl, 1.25
NaH2PO4, 0.5 MgCl2, 3.5 CaCl2, 26 NaHCO3, and 10 glucose. For miniature events,
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tetrodotoxin (TTX, 1 µM) was added to the bathing solution. Recordings where made
after nearby extracellular stimulation could no longer evoke a postsynaptic current (~5
min). For evoked EPSCs, a glass electrode filled with 1M NaCl was placed in the slice at
a 250 µm horizontal distance from the recorded cell and used to apply a series of
currents. Threshold was determined as the smallest amount of current able to elicit a fifty
percent response rate at a pulse width of 20 µsec. Stimulus intensity was changed by
increasing pulse duration while maintaining the threshold level of current. A series of
five intensities was applied (1x, 2x, 4x, 8x and 16x threshold). For each intensity level,
the responses to three stimulus presentations were averaged. A 50 Hz train of four
stimuli was applied to the slice using the maximum stimulus intensity (16x threshold).
The responses to five stimulus train presentations were averaged for individual cells.

Data analysis
Recordings were made with a Multiclamp-700A amplifier (Axon Instruments),
and only those with an access resistance less than 23 MΩ were accepted for analysis.
Recordings were terminated if the resistance increased more than 20% or if there was
other evidence of declining cell health. Data was digitized online (20 kHz) using
software from Axon Instruments. Data analysis for voltage clamp experiments was
performed using MiniAnalysis (Synaptosoft). Some intrinsic parameters were measured
using Clampfit (Axon Instruments). Evoked data was analyzed using Igor software
(Wavemetrics). Measurements are reported as means ±SEM. Student’s t-test (Excel), ztest (SigmaStat), one way ANOVA and repeated measures ANOVA (SPSS) were used to
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test for significance where appropriate, and p <0.05 was considered to be significant.
Cumulative probability plots were generated to compare control and PMG mEPSC
interevent interval (IEI) durations for LTS, FS and overall interneuron populations. For
LTS, 200 events from each of nine cells with mEPSC frequencies closest to the median
value were combined for a total of 1800 events per group. For FS, the first 300 events
from each of six cells were used per group. For overall interneuron populations, 300
events from each of 23 cells per group were used to ensure that all cell types were
represented. The data were fit with the exponential decay function: y = A1 exp(-x/t1) +
y0 and the percentage of IEI values that fell below a set duration threshold was
determined. The Kolmogorov-Smirnov test was used to test for significance, p <0.05
was considered to be significant.

Results

Excitatory input to the overall interneuron population is unchanged in PMG cortex
Recordings were made from a total of 73 control and 59 PMG interneurons using
the whole cell patch clamp technique. To determine whether excitatory synaptic input is
altered for interneurons in the freeze-lesion model, s- and mEPSCs were analyzed. The
sEPSC frequency ranged from 0.5- 22.3 Hz in both control and PMG populations. This
is similar to previously reported values for excitatory input to layer V pyramidal neurons
(160). Comparable ranges for sEPSC amplitude were also observed for control (11.545.4 mV) and PMG (13.9- 48.8 mV). Mean sEPSC frequency and mean amplitude were
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the same for events recorded from interneurons in PMG cortex compared to those in
control (Fig. 3.1). For mEPSCs, neither the frequency nor the amplitude of these events
was different in PMG cortex compared to control (Fig. 3.1). Furthermore, the frequency
of miniature events was not significantly different from that of the spontaneous events.
Calculated for individual cells, mEPSC frequency was 93 ±9% of sEPSC frequency in
control and 91 ±8% in PMG. In order to determine whether alterations occur that cannot
be detected when all interneurons are considered together, subpopulations were examined
separately.

FS and LTS interneurons receive different amounts of excitatory input in control cortex
To compare populations of interneurons, two groups were separated from each
other based on firing patterns and intrinsic properties. In a separate study of intrinsic
properties, we have found that interneuron subtypes exist in essentially the same
spectrum in PMG as they do in control. We can readily separate different subtypes, as
well as distinguish regular spiking neurons from interneurons (Chapter 2). This was
accomplished using two measures, (1) the difference between the peaks of the first and
final AHPs and (2) the total adaptation ratio. Once these groups were established, a
number of other intrinsic properties were evaluated and found to be consistent for each
cell type between control and PMG cortex. Several of those measures were used here to
confirm the classification of FS and LTS interneurons.
Interneurons were visually identified under DIC and then assigned to a subtype
category based on their responses to a series of depolarizing current steps producing both

84
low and high frequency firing patterns (Fig. 3.2). LTS interneurons fired two or three
temporally close action potentials in response to small current steps, followed by
adapting trains of action potentials in response to increased current (Fig. 3.2A,B). FS
interneurons fired high frequency action potential trains with little adaptation (Fig.
3.2C,D). Adaptation for individual cells was plotted against action potential halfwidth,
separating the two populations of interneurons (Fig. 3.2E,F). Input resistance, action
potential half width and AHP peak amplitude were also used to distinguish interneurons
here (Fig. 3.3). For both interneuron populations, these control measures were consistent
with previously reported values (60; 169).
For each interneuron subtype, levels of excitatory input were determined in
control. FS interneurons had a higher frequency of sEPSCs than LTS interneurons, and
mEPSC frequency was also greater in FS cells compared to LTS (Fig. 3.4). The
amplitude of spontaneous and miniature events was larger in FS compared to LTS
interneurons (Fig. 3.4), and rise time and decay for both sEPSCs and mEPSCs were faster
in FS cells than LTS cells (Table 3.1). These differences were maintained in PMG cortex
(Fig. 3.4, Table 3.1).

Excitatory input to interneurons is differentially altered in PMG cortex
For LTS interneurons, the mean frequency of spontaneous events was doubled in
PMG compared to control cortex (Fig. 3.4). This occurred without alteration of the mean
amplitude (Fig. 3.4F), rise time, or decay for these events (Table 3.1). There was also a
higher mean frequency of miniature events in PMG LTS interneurons compared to
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control, but no difference in amplitude (Fig. 3.4G,H). Interestingly, neither the
spontaneous nor the miniature event mean frequency was different in the PMG FS cell
population compared to control (Fig. 3.4). To take into account the variation within each
cell type, the range of frequencies was plotted with both the mean and median values for
that group (Fig. 3.5A-B). As expected for the PMG LTS population, the upper limit of
the range was increased, although the minimum value was the same (Fig. 3.5A). Not all
of the cells had a higher frequency in the LTS population, but both the mean and median
values were increased. In contrast, the action potential half-width, an intrinsic property
and defining quality of interneuron subtype, were unaffected (Fig. 3.5A). Interestingly,
neither the range of frequencies nor the mean frequency was different for PMG FS cells
compared to control; however, the median value for mEPSC frequency was lower in the
PMG FS population. As with the LTS interneurons, the action potential half-width
measurement remained unchanged (Fig. 3.5B).
Cumulative probability plots were generated (See Materials and Methods) to
compare the IEI distribution for the cells with mEPSC frequencies closest to the median
value in each group (Fig. 3.5C-E). Not surprisingly, there was a significant separation
between the distribution of the IEIs for control and PMG LTS cells (Fig. 3.5C). To
investigate this difference further, the percentage of IEIs that were shorter than the set
threshold of two seconds was compared between control and PMG. While 47% of the
IEIs in control LTS cells were shorter than two seconds, 85% of IEIs in PMG LTS cells
fell below this threshold. Unexpectedly, there was also a significant separation between
the control and PMG populations of FS cells (Fig. 3.5D). Due to the higher mEPSC
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frequency observed in FS cells, a 400 msec threshold was used. For control cells, 75% of
the IEIs were shorter in duration than the threshold, while for PMG FS cells, the IEIs
were typically longer, with only 42% of the IEIs falling below the threshold level. A
cumulative probability plot was also generated for interneurons without separating them
by subtype, and the distribution was similar for both control and PMG populations (Fig.
3.5E). A 900 msec threshold was set for these IEIs, with 66% and 46% falling below this
level for control and PMG, respectively.

Evoked responses
In response to a series of five stimuli with varied intensities, eEPSCs in both FS
and LTS interneurons were graded in size relative to the increase in stimulus intensity
(Fig. 3.6A,B). Some cells occasionally fired action potentials at the highest stimulus
intensities. The mean area of the eEPSC was larger for FS interneurons than LTS
interneurons (Fig. 3.6C). There was no significant difference in the threshold current
used to evoke these responses for any of the groups (Control LTS = 73 ±15 µA, Control
FS = 65 ±15 µA, PMG LTS = 65 ±10 µA, PMG FS = 31 ±4 µA, one-way ANOVA,
N.S.). Time-to-peak of the eEPSC was shorter for control FS interneurons than both
control and PMG LTS interneurons. There was, however, no difference in the time to
peak for PMG FS interneurons in comparison to any of the other cell groups (Fig. 3.6D).
The presence of all-or-none variable-latency evoked activity was also evaluated for each
cell in response to this series of stimuli. In control, 6/22 FS cells (27%) and 5/22 LTS
cells (23%) demonstrated this type of late activity on one or more sweeps. In PMG, it
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was present in 12/22 FS cells (55%) and 7/15 LTS cells (47%). Typically, late activity
was observed following application of the lower intensity stimuli (Fig. 3.6E,F). The
mean area of this activity was not different for control FS cells compared to either
population of LTS cells, but late activity in PMG FS interneurons had a larger area than
either control or PMG LTS interneurons (Fig. 3.6G).
Trains of four stimuli at a frequency of 50 Hz were also applied to the slice using
the maximum stimulus intensity established for the preceding series. As has been
previously reported, LTS cells demonstrated facilitating patterns, while FS cells had a
depressive pattern (276) in response to repetitive stimulation (Fig. 3.7). Cells were
identified as facilitating or depressive based on the percent change in eEPSC amplitude
between the first and fourth responses to the stimulus train. In control, all FS cells
showed depression, as expected (Fig. 3.7F). However, there were four control LTS cells
that did not show clear facilitation (19%). In PMG, four FS cells showed a slightly
facilitating response (18%). Only one PMG LTS cell was not facilitating (7%). There
were no differences between control and PMG populations regarding the proportion of
cells that demonstrated the expected, stereotypical response to repetitive stimuli (z-test,
N.S.). It is interesting to note that of the facilitating PMG FS cells, the amount of
facilitation between the first and fourth eEPSCs (159 ±27%) was not as extensive as is
typically seen in LTS interneurons (322 ±34% in control, 338 ±60% in PMG). Also,
while there was no significant difference in the characteristic response (facilitating vs.
depressive) for either interneuron subtype, the extent of the response was altered in PMG
cortex. In other words, the amount of depression in PMG FS cells was slightly increased
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compared to than that of control FS cells, as measured by the percent decrease in peak (ttest, p <0.05, Fig. 3.7C). For the LTS population, the percent increase in peak amplitude
for the final response was slightly larger in PMG LTS cells (t-test, p <0.05, Fig. 3.7D).

Increased probability of release causes increased sEPSC frequency in both PMG and
control
The increased s- and mEPSC frequencies observed in LTS interneurons could be
due to the presence of more glutamatergic terminals or an increased probability of release
from existing terminals. For this reason, sEPSCs were also recorded in modified aCSF
containing low Mg2+ and high Ca2+to increase the probability of presynaptic glutamate
release (see Materials and Methods). A percent increase in sEPSC frequency of roughly
equal magnitude was seen in the LTS cells from PMG (677 ±278 %) and control cortices
(470 ±190 %, Fig. 3.8). This increase included a wide range of values for individual cells
in both control and PMG cortex. In control LTS cells, this also reflected an increase in
mean frequency from 1.2 ± 0.2 Hz in normal aCSF to 6.4 ± 2.5 Hz in modified aCSF (ttest, p <0.05). In PMG, the corresponding values increased from 1.5 ±0.2 Hz to 9.9 ± 2.5
Hz (t-test, p <0.05). FS interneurons also demonstrated a similar level of increase
between control (100 ±61 %) and PMG (122 ±38 %) populations, as expected, although
their increase was much smaller than that of the LTS interneurons (Fig. 3.8). For neither
control nor PMG cortex was there an accompanying change in the amplitude of the
spontaneous events.
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Discussion
The main finding of this study is that there is a selective increase in excitatory
input to LTS interneurons in malformed, epileptogenic cortex. Additionally, there
appears to be a subtle decrease in excitatory input to FS cells in PMG cortex. This is not
reflected in the interneuron population as a whole; however, as sEPSC frequencies are
not different when comparisons between control and PMG cortex include all
interneurons.
After separating FS and LTS interneurons based on their intrinsic properties (13;
15; 28; 60; 61), we were able to note characteristic differences in physiological properties
for these two groups in control. The sEPSCs recorded from FS interneurons typically
have a higher frequency, larger amplitude and faster rise and decay times compared to
LTS cells (see Results). This is not surprising, as both thalamocortical and local
pyramidal cell inputs to FS cells tend to be reliable and precise (28; 330), while LTS cells
have more failures in response to pyramidal cell synaptic stimulation and receive weak
input from the thalamus (28). The characteristics that distinguish these two types of
interneurons are also related to the observation that the cells normally function within
separate networks. Electrically connected FS cells (28; 124; 131), for example, provide
powerful inhibition (330) and elicit fast IPSCs in pyramidal cells (369). This allows the
horizontally oriented FS cells that synapse on cell bodies (185) to powerfully and rapidly
effect feed-forward inhibition, while vertically oriented LTS cells (173) modulate activity
via dendritic synapses. Networks of LTS cells have a role in cortical synchrony (197)
and elicit slower IPSCs than FS cells, likely due to their distal synapse location (369).
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These two types of interneurons also have a differential response to acetylcholine (171;
368), further suggesting that they subserve different functions. Interestingly, under
control conditions in hippocampus, differences have also been demonstrated between the
excitatory input to dendrite-targeting and soma-targeting interneurons (81). In
hippocampus, for dendrite targeting interneurons, sEPSCs have been shown to be
dependent on action potential firing, but sEPSCs in soma-targeting interneurons were
largely independent of action potential firing (81).
Just as the balance of excitation and inhibition is important for normal cortical
function, we propose that an imbalance between the function of distinct inhibitory
networks may contribute to the observed electrophysiological abnormality in this model.
Inhibition itself was not measured directly for this study, but the EPSC frequency
measured in inhibitory cells demonstrates a selective increase in the PMG LTS
population, suggesting that LTS cells may more frequently be depolarized to threshold
potential in PMG cortex (Fig. 3.4). This in turn could create an increase in the inhibitory
influence provided by the LTS population, enhancing vertically-oriented inhibition (173;
174). Due to connectivity provided by gap junctions and the subsequent coordinated
activity of a number of LTS cells (197), this increase could result in columnar synchrony.
In contrast, other studies have demonstrated decreased excitatory input to interneurons
(367). While this may intuitively make more sense with regard to hyperexcitability, not
all models of hyperexcitability show decreased inhibition (50; 269). Although the mean
values for EPSC frequency were not different for FS cells, the separation between
mEPSC IEI distributions for control and PMG also suggests that there is at least a
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subpopulation of PMG FS cells receiving less excitatory input. The range of mEPSC
frequency is not different for PMG, and there is enough variation to produce similar
means for each group, however, the lower median value indicates a shift toward lower
mEPSC frequencies. The idea of decreased input to FS cells is also consistent with a
study that showed a selective decrease in the strength of inhibition from FS cells in layer
IV of somatosensory cortex (329). A loss of powerful feed-forward inhibition normally
mediated by these cells could result in the absence of regulation needed to prevent
uncontrolled spread of excitation.
Amplitude, rise time and decay were not altered in PMG for either LTS or FS
interneurons, suggesting that the observed alterations in frequency comprise a presynaptic phenomenon. In addition, the observed sEPSC frequencies were very close to
the mEPSC frequencies, indicating that under these conditions, there is a limited amount
of spontaneous activity (Fig. 3.4). This suggests that the increased sEPSC frequency in
PMG LTS cells is not action potential-dependent. Rather, the increased mEPSC
frequency supports the idea that increased afferent contacts selective to the LTS cell
population underlie increased excitation. In fact, previous work has suggested the
possibility of increased excitatory drive on interneurons that occurs in a specific, nonrandom fashion (160). However, altered probability of release at the excitatory synapses
could also have a role in the observed changes. To evaluate this, modified aCSF
(containing high Ca2+/low Mg2+), was applied to enhance neurotransmitter release
probability (352). We expected that if LTS cells in PMG cortex receive increased input
due to a greater number of afferent fibers, the percent increase in frequency should mirror
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that of the control population, which it did (Fig. 3.8). A lesion-induced increase in
presynaptic release probability for excitatory synapses on LTS cells would likely render
their response to the modified aCSF similar to the smaller response seen in FS cells. The
FS cells were expected to respond less robustly, as they are more reliably excited by
presynaptic excitation (330) and have higher sEPSC frequency under normal conditions
(Fig. 3.4). Conversely, if the probability of release was decreased in PMG FS cells, we
would have expected to see a “rescue” effect following application of modified aCSF.
While these data do not definitively prove that probability of release from excitatory
synapses on interneurons is unaltered in this model, the idea of an altered number of
afferent fibers and synapses is supported by other data that suggest an anatomical
reorganization of afferent inputs (286). Ultrastructural studies to determine the number
of excitatory synapses on interneuron subtypes would help clarify this issue. Ultimately,
complex alterations to a number of characteristics may contribute to the observed
changes, and our methods may be unable to distinguish each component.
It has been previously reported that FS cells exhibit a depressive response to
repeated stimuli, while LTS cells show facilitation (276). Here, a 50 Hz stimulus train
evoked depressive responses from FS cells and facilitating responses from LTS cells,
with few exceptions. FS cells typically receive strong glutamatergic input from terminals
that release enough neurotransmitter to produce a reliable postsynaptic response,
resulting in depleted glutamate stores and their depressive response after repeated
stimulation. Perhaps suggestive of a slight increase in release probability for the PMG
FS neurons, “greater depression” was observed in these cells (Fig. 3.7). A subtle increase
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in the probability of release would make more glutamate available to be used in response
to the later stimulations. For the LTS cells, facilitation is explained by the presence of
glutamate in the presynaptic terminal that is only released subsequent to repetitive
stimulation and increased calcium influx. Had release probability in PMG LTS cells
already been increased, their response to repetitive stimulation would be expected to lose
at least some facilitation, as the glutamate would be released at lower stimulus intensities
under those conditions. The majority of LTS cells still responded to the stimulus train
with a facilitating response, demonstrating that they did not exhaust glutamate stores and
could still produce facilitating responses in PMG cortex (Fig. 3.7). However, if PMG
LTS interneurons have a larger number of afferents, they should then have larger
responses to threshold stimuli. Surprisingly, the area of the evoked response was not
different in PMG cortex when compared to control. It is possible that the number of
additional afferents required to double the initially low frequency of LTS interneurons
might not be sufficient to cause a significantly increased evoked response, especially if
there is a concomitant alteration in release probability. Interestingly, another indirect
measurement of aberrant excitatory input, late evoked activity, was observed in twice as
many PMG interneurons as in control (see Results and Fig. 3.6). This type of activity
reflects excitation that resonates in the cortex prior to eliciting a postsynaptic response in
the recorded cell. The increased FS activity is a good indicator of increased excitation in
the cortex, due to the reliable response to synaptic input seen in this cell type (28; 330).
An intricate connectivity between excitatory and inhibitory cells that is only
partially understood defines cortical organization and can be disrupted during
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development. For example, as the cortex matures, FS and LTS cells develop distinct
relationships with neighboring pyramidal cells. FS cells form reciprocal connections that
are stronger than one-way connections, while LTS cells do not have this same propensity
(371). In addition, whether or not spatially related FS and pyramidal cells will receive
excitatory input from the same afferents is dependent on these reciprocal partnerships,
while for LTS cells, it is not (371). When the freeze-lesion is made, neuronal death
causes some incoming glutamatergic afferents to be deprived of their targets. In
particular, it appears that a number of FS cells are lost, evidenced by the decrease in PVimmunopositive cells (288). Even though thalamic and callosal afferents originally
destined for the gyrus appear to hyperinnervate the paramicrogyral area (155; 286), there
may be fewer pyramidal- FS pairs to receive these inputs. One potential consequence of
this could be a decrease in the FS cell efficacy. If these interneurons are not stimulated at
the same time as neighboring pyramidal cells, their role in feed-forward inhibition and
control of horizontally spreading excitation could be hindered. Also relevant to this study
is the potential availability of more glutamatergic afferents for the surviving pyramidal
and LTS cells. The vertical orientation of LTS cells means that dendrites connected to
layer V cell bodies may be located in layer IV, the main target of thalamic afferent fibers.
Increased thalamic afferents could contribute to the increased EPSC frequency seen in
these cells. Additionally, while a large number of afferents may come from projecting
sources, it is also possible that local pyramidal cells will show sprouting and increased
axonal development, as is seen in the undercut model of post-traumatic epilepsy (294).
In fact, recordings of in vitro epileptiform activity evoked by thalamic stimulation
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suggest that the hyperexcitability relies on intracortical circuits more than thalamic input
(329).
Although it was not addressed in this study, synaptic inhibition between
interneuron subtypes may be affected as well. In normal cortex, FS cells synaptically
inhibit LTS cells, but LTS cells tend not to inhibit each other (131). The presence of
fewer or “less active” FS cells might result in decreased IPSC frequency for both
interneuron populations. However, if other alterations occur, such as aberrant increased
LTS-LTS synaptic inhibition, the extra excitatory input observed in this cell type may be
“canceled out” and not cause the expected post-synaptic depolarization. It would be
interesting to study the inhibitory input to these interneuron subtypes as well for this
reason. It is known that FS cell IPSCs tend to be faster and larger than those in LTS
cells, and eIPSCs often require higher stimulus intensities in LTS cells (15).
Furthermore, the overall frequency of mIPSCs is unchanged in this model, indicating that
if probability of release is not altered, the total number of inhibitory synapses is
unchanged (160). It may be difficult to accurately assess inhibitory function in the slice
preparation (269), but a general comparison between inhibition and excitation within a
given subtype should help address this question.
The contribution of interneurons to the development of epileptogenesis occurs
in the context of increased excitation and will take a significant amount of investigation
to satisfactorily resolve. At this point we suggest that as extra afferent fibers infiltrate the
area adjacent to the lesion during the first week or two of development, they have fewer
potential targets. To make up for this, hyperinnervation of certain cells occurs, producing
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increased excitation of pyramidal cells (375) and selectively increasing excitatory events
in LTS cells (Fig. 3.4). Although current seizure treatment strategies may contradict the
idea of increased inhibition as a causative epileptogenic factor, a number of studies point
to the maintenance or even enhancement of inhibition in epileptogenic cortex (50; 55;
269; 293). Focusing on one specific interneuron subtype helps to address some confusion
regarding how this paradox exists. In the model used for this study, overall inhibition
does not show an obvious change, but selective alterations of inhibitory subtypes may
permit functional consequences while still allowing for maintenance of global inhibition.
Even a subtle increase in the activation of LTS interneurons could cause asymmetry in
the inhibitory population in the form of increased output of vertically-oriented
interneurons, which may be a contributing factor to epileptogenesis in this model.
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Table 3.1 Properties of spontaneous and
miniature postsynaptic currents.
10-90 Rise
(msec)*

Decay
(msec)*

Area
(pA*sec)#

Control LTS
PMG LTS

1.1 ±0.05
1.0 ±0.04

6.0 ±0.2
5.4 ±0.2

70.2 ±3.3
67.2 ±4.1

Control FS
PMG FS

0.65 ±0.02
0.71 ±0.04

4.3 ±0.1
4.3 ±0.2

66.2 ±2.1
64.7 ±3.5

1.1 ±0.05
1.1 ±0.08

5.9 ±0.3
5.7 ±0.4

69.0 ±4.7
64.0 ±5.5

sEPSCs

mEPSCs
Control LTS
PMG LTS
Control FS
PMG FS

0.64 ±0.04 4.1 ±0.1 58.1 ±2.2
0.68 ±0.05 4.1 ±0.1 56.1 ±3.0
* Significant difference between FS and
LTS populations, t-test, p <0.05
# Significant difference between FS and
LTS for control mEPSC only, t-test, p< 0.05
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Figure 3.1 Excitatory post-synaptic currents in inhibitory cells. Isolated outward
excitatory currents recorded in normal aCSF (sEPSCs, A), and in the presence of TTX
(mEPSCs, B). Mean sEPSC frequency (C) and amplitude (D) for all interneurons in
control (gray, n = 73) and PMG (black, n =59) populations. Mean mEPSC frequency (E)
and amplitude (F) for all interneurons in control (gray, n = 32) and PMG (black, n = 25)
populations. There were no significant differences between control and PMG
populations on any measure, t-tests.
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Figure 3.2 Sample traces demonstrating typical firing patterns for LTS and FS
interneurons. Responses to high (1) and low (2) current steps are shown for (A) control
LTS, (B) PMG LTS, (C) control FS, and (D) PMG FS interneurons. Average action
potential half-width plotted against total adaptation ratio for individual LTS (open
square) and FS (filled triangle) interneurons from (E) control and (F) PMG cortex.
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Figure 3.3 Classification of interneuron subtypes based on intrinsic properties. FS
and LTS interneurons could be differentiated from each other in control (gray, n = 39 for
FS, n = 35 for LTS) and PMG (black, n = 29 for FS, n = 41 for LTS) populations based
on (A) input resistance, (B) mean action potential half-width and (C) total adaptation.
Total adaptation is the ratio of the frequency of the last two action potentials and the
frequency of the first two action potentials fired in response to a 400 ms square current
pulse. * = t-test, p <0.05.
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Figure 3.4 Excitatory post-synaptic currents in FS and LTS interneurons. Sample
traces showing typical mEPSCs recorded from FS interneurons in (A) control and (B)
PMG, and typical mEPSCs recorded from LTS interneurons in (C) control and (D) PMG.
Mean sEPSC frequency (E) and amplitude (F) measured in control (gray, n = 31 for LTS,
n = 33 for FS) and PMG (black, n = 23 for LTS, n = 28 for FS) populations. Mean
mEPSC frequency (G) and amplitude (H) measured in control (gray, n = 14 for LTS, n =
17 for FS) and PMG (black, n = 9 for LTS, n = 12 for FS) populations. * = t-test, p <0.05.
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Figure 3.5 Population distribution and IEI cumulative probability for mEPSCs.
Population distribution is altered for synaptic but not intrinsic measures in LTS cells
only. Shown are the distribution limits (maximum and minimum) as well as mean (x)
and median (-) for each population, with AP halfwidth plotted on the left axis and
mEPSC frequency plotted on the right axis. Control is shown with gray-filled symbols,
PMG with black-filled symbols for (A) LTS interneurons and (B) FS interneurons.
Cumulative probability of mEPSC IEI duration is altered for LTS and FS interneurons,
but not for the overall interneuron population. Control is shown with gray line, PMG
with black line. (C) Cumulative probability of IEI duration for LTS cells. For control
and PMG, nine representative LTS cells were chosen from each group that had mEPSC
frequencies closest to the median, and 200 events per cell were used for a total of 1800
events. Significant separation between control and PMG distributions, KolmogorovSmirnov test, p <0.05. (D) Cumulative probability of IEI duration for FS cells. For
control and PMG, 300 events were used from each of six representative cells, for a total
of 1800 events per group. Significant separation between control and PMG distributions,
Kolmogorov-Smirnov test, p <0.05. (E) Cumulative probability of IEI duration for
overall interneuron population. For control and PMG, 300 events from each of twenty
three representative cells were included, for a total of 6900 events.

107

108

Figure 3.6 Evoked postsynaptic currents. (A-B) Sample traces demonstrating the
short-latency inward eEPSC recorded from interneurons following a series of five applied
current intensities (1x, 2x, 4x, 8x, 16x threshold). (A) Graded responses in a
representative LTS cell from control (1) and PMG (2) cortex. (B) Graded responses in a
representative FS cell from (1) control and (2) PMG cortex. (C) eEPSC area and (D)
time-to-peak for short latency inward EPSCs is shown for all five stimulus intensities in
control (filled symbols, n = 22 for LTS, n = 22 for FS) and PMG (open symbols, n = 15
for LTS, n = 22 for FS). For the area measurement shown in (C), both LTS populations
(control and PMG) are different from both FS populations (control and PMG), repeated
measures ANOVA, p <0.05. For time-to-peak measurement shown in (D), control and
PMG LTS populations are not different from one another, control FS is different from all
other cell populations, repeated measures ANOVA, p <0.05. (E-F) Sample traces
demonstrating the presence of variable-latency evoked activity in response to a low
intensity stimulus (left, corresponding to 200 pA vertical measurement on scale bar)
compared to a normal response to high intensity stimulation (right, corresponding to 400
pA vertical measurement on scale bar) in (E) a control FS cell and (F) a PMG FS cell.
(G) eEPSC area for variable-latency activity is plotted against stimulus intensities for
control (filled symbols, n = 22 for LTS, n = 22 for FS) and PMG (open symbols, n = 15
for LTS, n = 22 for FS) cells. For late activity, control FS, control LTS, and PMG LTS
cells are not different from each other. PMG FS cells differ from both control and PMG
LTS cells on this measure, repeated measures ANOVA, p <0.05.
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Figure 3.7 Interneuron response to a 50Hz train of stimuli at maximal intensity
(16x threshold). Sample eEPSC traces demonstrating (A) facilitation in control (1) and
PMG (2) LTS interneurons and (B) depression in control (1) and PMG (2) FS
interneurons. (C) Percent change for each eEPSC peak compared to the preceding peak
(relative comparison) for FS interneurons, t-test, * p <0.05. (D) Percent change for each
eEPSC peak compared to the preceding peak for LTS interneurons, t-test, * p <0.05. (F)
Percent change in peak for each eEPSC, compared to the first eEPSC (absolute
comparison) for LTS and FS interneurons from both control and PMG cortex, t-tests, all
N.S. For all graphs, control LTS, filled circle, n = 21; PMG LTS, open circle, n = 15;
control FS, filled triangle, n = 19; PMG FS, open triangle, n = 20.
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Figure 3.8 Effect of altering aCSF Mg2+ and Ca2+ concentrations on sEPSC
frequency. (A) Sample traces demonstrating typical sEPSCs in a control LTS
interneuron, recorded in (1) normal aCSF and (2) modified (low Mg2+/High Ca2+) aCSF.
(B) Typical sEPSCs recorded from a PMG LTS interneuron in (1) normal aCSF and (2)
modified aCSF. (C) Mean percent change in sEPSC frequency for individual cells in
control (gray, n = 8 for LTS, n = 6 for FS) and PMG (black, n = 5 for LTS, n = 5 for FS)
populations. t-test, N.S.
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Chapter 4
Introduction to metabotropic glutamate receptors

There are two main receptor types that mediate the cellular response to glutamate,
the major excitatory neurotransmitter of the central nervous system. Fast excitatory
transmission is mediated by ionotropic receptors that regulate the opening of cationpermeable channels in the neuronal membrane. The three main ionotropic receptor
subtypes are: (1) the AMPA receptor, (2) the kainite receptor, and (3) the NMDA
receptor. Functioning on a slower time scale, metabotropic glutamate receptors (mGluR)
are coupled to G-proteins that initiate intracellular signaling cascades in response to
glutamate (320). In contrast to ionotropic glutamate receptors, mGluRs are typically
considered to have modulatory roles within the neocortex. As more is learned about
these receptors and their physiological functions, it is increasingly possible to assign
them potential roles in pathological processes, including epilepsy. The purpose of this
chapter is to: (1) introduce the characteristics and developmental expression patterns of
mGluRs, (2) establish the utility of mGluRs and their ligands for the pharmacological
manipulation of specific interneuron subtypes, and (3) review their current and potential
associations with disease states, including epilepsy.
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4.1 Classification and function of mGluRs
Eight different subtypes of mGluRs have been identified and segregated into three
main groups based on amino acid sequence and mechanism of intracellular signal
transduction. Group I contains mGluR1 and mGluR5, group II contains mGluR2 and
mGluR3, and group III contains mGluR4, mGluR6, mGluR7 and mGluR8 (77; 261; 339).
The majority of group I receptors are located postsynaptically (58; 204), while most of
the group II and III receptors are located on the presynaptic membrane (58; 302). As
group I mGluRs are of particular interest to the experiments described in the next chapter,
the remainder of this introduction will focus on those receptors.
The signaling mechanism of group I mGluRs involves activation of
phospholipase C and subsequent phosphoinositide hydrolysis, ultimately resulting in the
production of diacylglycerol and release of calcium from intracellular stores (261). There
are differences between the mGluR1 and mGluR5 subtypes with regard to calcium
increase and oscillations. In transfected cell lines, glutamate application causes
intracellular calcium oscillations following activation of mGluR5, but not mGluR1 (168).
The distinction appears to be due to PKC phosphorylation of a threonine residue only
found on the mGlu5 receptor (168). In immature rat neocortex, agonist application
induces simple, non-oscillatory calcium responses from mGluR1 activation, but it causes
oscillations through the mGlu5 receptor (113). However, in striatal cholinergic
interneurons, which express both mGluR1 and mGluR5, only after blocking mGluR5 is
oscillatory behavior observed (43). The mechanism for these oscillations appears to
involve both tyrosine kinase and L-type Ca2+ channels (43). It appears that both subtypes
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of receptor are capable of inducing membrane oscillations, but this may depend on the
cell type, source of calcium, and type of agonist used to elicit the response.

4.2 Ligands for mGluRs

4.2.1 Group I agonists
There are several known non-selective agonists to the group I mGluRs, such as
quisqualate and, of course, glutamate (280). In the 1980s and early 1990s, the first
selective agonist for mGluRs was identified. 1S,3R-1-aminocyclopentane-trans-1,3dicarboxylic acid (ACPD) was determined to activate mGluRs at concentrations that do
not affect the ionotropic receptors (EC50 in the range of 10-50 µM, 305). Since the
discovery of ACPD, a number of compounds with increased selectivity have been
identified or synthesized and are commonly used to distinguish the effects of mGluR
subtypes.
The phenylglycine derivative (S)-3,5-dihydroxyphenylglycine (DHPG) is the
first agent to demonstrate selective and potent group I mGluR agonist activity (154; 305;
310). DHPG does not affect the level of cAMP in neonatal or adult rat brain, even with
DHPG at a concentration of 1 mM (304). This indicates that it lacks activity at mGluRs
that make use of the cAMP second messenger system, namely group II and group III
(304). In oocytes expressing mGluR1, the experimentally determined EC50 for DHPG
(60µM) was lower than that of ACPD, but higher than that needed to activate group I
mGluRs in rat brain tissue (154). In rat, the EC50 for DHPG ranges from 7 µM for
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neonatal brain slices to 28 µM in adults (304). DHPG is currently the drug of choice for
studies in which selective activation of group I mGluRs is necessary. For the
experiments in Chapter 5, DHPG was used at a concentration of 10 µM.
Currently, there is no specific agonist for mGluR1, but (RS)-2-Chloro-5Hydroxyphenylglycine (CHPG), has recently been synthesized as a selective agonist for
the mGlu5 receptor (95). As evidence of this, CHPG-induced CREB phosphorylation
and its downstream effects were reversed by specific mGluR5 antagonism but were
unaffected by antagonists to mGluR1 (208). CHPG has also been shown to activate
mGluR5 in vivo, and again this response is selectively reduced by antagonists specific for
mGluR5 but not mGluR1 (295). The hippocampal cellular response to CHPG activation
of mGluR5 involves modulation of NMDA receptor- induced depolarization (95), but this
is not reflected in the present study, as NMDA receptors were blocked. For the
experiments in the following chapter, CHPG was used at a concentration equal to its
EC50, 750 µM (95).

4.2.2 Group I antagonists
There are a number of well-characterized and selective antagonists for the group I
mGluRs. The mGluR1-specific antagonist used for the experiments described in the next
chapter is 1-Aminoindan-1,5-dicarboxylic Acid (AIDA). AIDA is a potent, selective and
competitive mGluR1α antagonist (254). In cells transfected with mGluR1α, AIDA was
able to reduce glutamate-induced phosphoinositide synthesis, successfully inhibiting the
activity of the mGlu1 receptor, while having a much smaller effect on the activity of
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mGluR5 (231). The range of EC50 values spans from 7 µM to 214 µM, though this is
likely due to the variety of both the experimental conditions and the agonists used (231).
At very high concentrations (1mM), weak agonist activity on the mGlu2 receptor and
weak antagonism of the ACPD effect on mGlu5a receptors were observed (305). The
concentration of AIDA needed to achieve these responses, however, was greater than
three times the concentration used for the experiments in the following chapter. Of the
other compounds that have been identified as mGluR1α-specific antagonists, many have
activity at other receptors, depending on the concentrations used (305). Comparatively,
AIDA must be applied at a concentration many-fold higher than its EC50 to
promiscuously activate receptors besides mGluR1.
Finally, 2-methyl-6-(phenylethynyl)-pyridine (MPEP) is the selective mGluR5
antagonist used for these experiments (305). It is a non-competitive antagonist that binds
at a novel allosteric site (127). MPEP has been shown to inhibit phosphoinositide
hydrolysis in cells expressing the human mGluR5 (245), neonatal rat brain slices (127). It
also reduces DHPG-induced excitation, recorded in vivo from adult rat hippocampus
(127). In cells expressing rat mGluR5, MPEP also demonstrated inverse agonist activity
(245). Specific residues in transmembrane domains III and VII are necessary for the
selective binding of MPEP to mGluR5 (245). The proposed mechanism of action of
MPEP is stabilization of the inactive conformation of the mGluR5 receptor within the
membrane (191). Recently, electrophysiological effects of MPEP on ionotropic
glutamate receptors have been reported (191). However, for the experiments discussed
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here, AMPA and NMDA receptors were pharmacologically blocked, allowing MPEP to
effectively discriminate between mGluR1 and mGluR5.

4.3 Development and expression of group I mGluRs
The presence of group I mGluRs has been demonstrated in neocortex through in
situ hybridization (314) and immunohistochemistry (198; 281). Both immunogold and
immunohistochemical labeling indicate that the group I receptors are located primarily on
postsynaptic elements (313; 315), but largely outside the synaptic specialization (24;
242). Various forms of mGluR1 are present in cell bodies throughout the layers of
neocortex, sometimes with region-specific splice variant expression (107). Furthermore,
in neocortex, mGluR1 immunostaining is present in interneurons only (256). Doublelabeling studies indicate that mGluR1 colocalizes with SS and VIP, but not PV,
demonstrating that expression of the mGlu1 receptor is restricted further to a specific
interneuron subpopulation (24; 326). This is supported by an in-situ hybridization study
that shows mGluR1 mRNA in interneurons that contain SS but not PV (177).
Furthermore, mGluR5 mRNA was shown to be present in projection neurons and some
interneurons but was almost completely absent from SS interneurons (177). It has also
been demonstrated in striatum that the expression of mGluR5 mRNA is specifically
absent from SS and cholinergic interneurons (343). This specificity is employed in the
following chapter, as mGluR1 agonists are used to selectively activate the SS/LTS
interneuron type.
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Each mGluR has a different, dynamic pattern of expression throughout
development. In the rat, mGluR5 has its highest transcript expression in utero and during
the first days of postnatal life, while mGluR1 mRNA gradually increases to adult levels
over the first three postnatal weeks (59). In the adult, less than ten percent of all neuronal
cells express mGluR1, and most are scattered in cortical layers IV-VI (314). This pattern
of mGluR1 expression can be recognized as early as P7 (59) and is relatively established
by P11 (314), although some increase still occurs until P21 (59). In a complementary
immunohistochemical study, the prevalence of the mGluR1 protein increases postnatally,
so that by P15, interneurons with bipolar or multipolar morphology express it in all layers
of neocortex (198). Conversely, there is strong mGluR5 expression from P0 to P2. After
one week, mGluR5 can be observed in the neuropil, particularly in layer IV barrel
hollows until P21, when all layers approached the same level of neuropil labeling (198).
The experiments in chapter 5 are performed during the third postnatal week, and both
mGluR1 and mGluR5 should be approaching mature distributions at that time.

4.4 Potential role for group I mGluRs in pathological states
With regard to disease processes, activation of group I mGluRs tends to be
detrimental to the nervous system, while activation of group II and III is considered to be
neuroprotective (116; 163; 238; 333). Different studies have implicated the group I
mGluRs in neurological injury and a variety of disease states, such as Alzheimer disease,
Huntington disease, Parkinson disease, Down syndrome and epilepsy (11; 40; 45; 58;
234; 244). For epilepsy in particular, analyses of both human tissue samples and
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experimental models have demonstrated an alteration of mGluR expression (96). For
example, in two animal models of epilepsy, as well as in human cases, there is a selective
upregulation of mRNA and protein expression of the mGlu1 receptor subtype (40).
Immunohistochemistry shows an upregulation of both mGluR1 and mGluR5 in patients
with glioneuronal tumors and intractable epilepsy (11). Patients with Taylor-type focal
cortical dysplasia (8) and temporal lobe epilepsy (40; 241) also show an upregulation of
one or both group I mGluRs. Much attention has recently been placed on the mGlu5
receptor as a potential contributor to the pathophysiology of Fragile X syndrome, a
condition that includes, among other symptoms, seizures and abnormal neuronal
morphology (58). The ibotenate injection model, that produces a cortical injury similar
to the freeze-lesion used for these studies, demonstrates a significant increase in mGluR5
expression in the contralateral hippocampus one week post-injection (233). Group I
receptors are also increased in the uninjured CA1 and DG regions of the hippocampal
formation in these animals (233). Furthermore, as activation of group I receptors has a
proconvulsant effect (229), pharmacological agents that antagonize these receptors are
being identified as potential treatment options for some of these conditions (247).
A number of studies that have investigated the role of group I mGluR activation
with regard to epileptiform activity have done so in the presence of GABA antagonists,
using disinhibition to induce hyperexcitability (221; 222; 298; 345). One advantage of
this inhibitory blockade is that it facilitates the observation of mGluR-mediated
pyramidal cell activation. The idea of using group I mGluR antagonists as
anticonvulsants would, in this paradigm, depend on their ability to reduce the excitatory
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or bursting activity in the pyramidal cells (222). However, blocking GABA receptors
also disallows evaluation of the potential mGluR-mediated interneuron contribution to
epileptogenesis. It is necessary to address this possibility for several reasons. Firstly, the
SS/LTS interneuron subtype that expresses mGluR1 receptors (177; 326) also receives
extra excitatory input (Chapter 3) and has increased action potential firing capability
(Chapter 2) in this model. This increased input has the potential to translate into
enhanced output from this specific group of interneurons. This is important because, as
discussed in chapter 1, LTS/SS cells have a vertical axon distribution that can span
several cortical layers (173; 174) and they function within a coordinated network to
generate synchronous activity in cortex (197). Enhanced cortical synchrony could then
promote epileptiform activity. The following experiments employ the specific agonists
and antagonists discussed in this chapter to selectively manipulate the activity of LTS/SS
interneurons. The goal of this study, especially in light of the findings from chapters 2
and 3, is to determine whether the output of LTS/SS interneurons is augmented. This
would provide a potential mechanism for columnar synchrony and the impetus for future
studies on the network properties of these cells.

Chapter 5
Enhanced Responsiveness of Interneurons to Group I Metabotropic Glutamate
Receptors in Malformed Epileptogenic Cortex

Introduction
Epilepsy caused by developmental cortical malformations, such as
polymicrogyria (52; 70; 88; 140), produces seizures that are difficult to treat (188; 246).
In this study we employ a rat model that closely approximates the human condition with
regard to both histopathology (99; 100) and hyperexcitability (156; 157). Previous work
with this model has suggested that neurons adjacent to the malformed region are
hyperinnervated by excitatory afferents (160; 375). Inhibitory as well as pyramidal
neurons receive this increased synaptic input (160).
Interneurons are affected in this model, but inhibition does not show a clear
decrease when measured as a whole (269). However, immunohistochemical studies in
this model have demonstrated a differential effect on inhibitory interneurons, based on
subtype. A down-regulation of parvalbumin (PV) staining has been demonstrated (288),
but the number of calbindin (CB)-immunopositive interneurons has been shown to
increase (308). These two markers co-localize, but the populations are not completely
overlapping, and this appears to be specific to layer II/III (184). Furthermore, the CB cell
population contains a separate overlap with the SS cells (174). The number of SS
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interneurons remains unchanged at the age of hyperexcitability onset (250). These results
indicate that either the number of inhibitory cells is altered in this model, or the number
of cells is the same but they have altered protein expression and enhanced or diminished
functional capability.
With regard to function, the subset of SS interneurons is of particular interest for
this study. SS interneurons are part of the class of bipolar, vertically-oriented, lowthreshold-spiking (LTS) cells (60; 170; 172). They also express the mGlu1 receptor, a
characteristic they share with at least one other subtype of bipolar interneurons, those
staining for vasoactive intestinal peptide (326). Bipolar cells normally provide a
relatively weak, modulatory inhibition. In contrast, the horizontally-oriented population
of interneurons is made up of PV-immunopositive (170) fast-spiking (FS) cells (170;
172) that do not express mGluR1 (326). The basket cell morphology of FS cells permits
them to provide powerful inhibition at the cell body or axon initial segment.
If one or more interneuron subtypes have diminished efficacy due to low cell
number or activity, the observed maintenance of global inhibition could result from the
compensatory over-functioning of another type. Here, we investigated whether the
output of bipolar interneurons is enhanced in PMG cortex, specifically within layer V.
These cells are orientated to have contacts within several layers of the same cortical
column. Increased efficacy may give them the potential to create columnar synchrony,
and thereby promote epileptogenesis. Selective activation of bipolar interneurons,
including SS/LTS cells, by group I mGluR agonists has previously been shown (73; 373).
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Using various ligands for group I mGluRs, these studies evaluate group I mGluR-induced
output by recording sIPSCs in layer V pyramidal cells.

Materials and Methods

Freeze lesion surgery
These experiments were done in accordance with the policies and guidelines of
Virginia Commonwealth University regarding care and use of animals. Freeze lesions
were made as previously described (375). Rat pups aged postnatal day (P)1 were
anesthetized with hypothermia by placing them in ice for 4-5 minutes. Using an anteriorposterior incision, the skull was exposed, and a freeze probe consisting of a copper bar
with a 2 by 5 mm rectangular tip cooled to -50◦ C was applied to the skull over the left
somatosensory cortex for 5 seconds. The skin was sutured, the pup warmed and returned
to the dam.

In vitro slice preparation
Lesioned animals and unoperated control rats aged P12-17 were anesthetized with
isoflurane and decapitated. The brain was removed and immediately placed into cold
(4◦C) sucrose slicing solution containing (in mM): 2.5 KCl, 1.25 NaH2PO4, 10 MgCl2, 0.5
CaCl2, 26NaHCO3, 11 glucose, and 234 sucrose. Slices 300 µm thick were cut on a
vibratome and transferred to a holding chamber filled with ‘normal’ artificial
cerebrospinal fluid (aCSF) containing (in mM): 126 NaCl, 5 KCl, 1.25 NaH2PO4, 2
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MgCl2, 2 CaCl2, 26 NaHCO3, and 10 glucose, 285-290 mOsm. All solutions were
infused with 95%O2/5%CO2, maintaining pH at 7.4. Sections were maintained at 34◦C
for 45 minutes and at room temperature thereafter. To isolate layer V interneurons and
eliminate the influence of other cortical layers, horizontal slices were used for all
recordings from pyramidal neurons in this study. Recordings from interneurons were
made within layer V in coronal slices. In all cases, recordings were made at 30-32oC, in
normal aCSF containing dinitroquinoxaline [(6,7)],2,3(1H,4H)-dione (DNQX, 20 µM)
and D,L-2-amino-5-phosphonopentanoic acid (APV, 100 µM) to block AMPA and
NMDA receptors, respectively.

Electrophysiology
Whole cell patch-clamp recordings from layer V pyramidal neurons (Fig 1) in
somatosensory cortex were obtained using glass micropipettes (2-5 MΩ, Garner glass
Co., Claremont, CA) filled with (in mM): 70 K-gluconate, 70KCl, 10 Hepes, 4 EGTA, 2
NaCl, 4 Na-ATP, 0.3 Na-GTP, 275-285 mOsm, ECl- = -15 mV, pH 7.3. Recordings were
made from an area of cortex 0.5-1.5 mm on either side of the lesion and from homotopic
cortex in controls. Spontaneous inhibitory postsynaptic currents (sIPSCs) were recorded
in isolation in voltage clamp mode at Vh = -70 mV (Fig. 1B). Current clamp recordings
were made from interneurons using glass pipettes as described above, that contained (in
mM): 130 K-gluconate, 10 Hepes, 11 EGTA, 2 MgCl2*6H2O, 2 CaCl2*2H2O, 4 NaATP, 0.2 Na-GTP, 275-285 mOsm.
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Recordings were made with a Multiclamp-700A amplifier (Axon Instruments),
and only recordings with an access resistance less than 23 MΩ were accepted for
analysis. Data was digitized online (20 kHz) using software from Axon Instruments.
Data analysis for voltage clamp experiments was performed using MiniAnalysis
(Synaptosoft). Amplitude measurements were made on ‘Type I’ events, which are
isolated (no overlap with adjacent events) currents. Since the max decay time was ~20
msec, events having an interevent interval of 40 msec or more were identified as Type I.
Some intrinsic parameters were measured using Clampfit (Axon Instruments).
Measurements are reported as means ± SEM. Student’s t-test with or without Bonferroni
correction (as indicated), as well as one-way and two-way ANOVAs were used to test for
significance, p <0.05 was considered to be significant.

Pharmacological agents and application
Ligands for group I mGluRs were applied using a four-barrel local perfusion
system. The first recording was made with normal aCSF flowing in the local perfusion
line. A second data file was collected during which the local perfusion was switched to
aCSF containing one or more drugs active at group I mGluRs. This recording was
continued for ~1 minute after the drug application began, during which time the response
stabilized (Fig 2A). After this period, separate data files were collected for analysis.
The pharmacological agents used in the local perfusion system were as follows: S-3,5dihydroxyphenylglycine hydrate (DHPG, group I mGluR agonist, 10 µM); 6-methyl-2(phenylethynyl) pyridine hydrochloride (MPEP, mGluR5-specific antagonist, 10 µM); 1-

128
amino-2,3-dihydro-1H-indene-1,5-dicarboxylic acid (AIDA, mGluR1-specific
antagonist; 30 µM, 100 µM, 300 µM); (RS)-2-chloro-5-hydroxyphenylglycine (CHPG,
mGluR5-specific agonist, 750 µM). For some experiments, MPEP and AIDA were
applied in the bathing solution at concentrations specified above. For interneuron
recordings, MPEP (10 µM) was included in the bathing solution and DHPG was applied
at a variety of concentrations (1 µM, 10 µM, 100 µM, 200 µM).

Results
Recordings were made from a total of 93 control and 83 PMG pyramidal neurons.
Overall health of the recorded neurons was consistent across both cell populations, based
on intrinsic properties of resting membrane potential, input resistance, membrane time
constant, and action potential amplitude (Table 5.1). All recordings were made at a
holding potential of -70 mV in aCSF containing APV (100 µM) and DNQX (20 µM),
limiting these measurements to monosynaptic IPSCs that could be abolished with
application of the GABAA antagonist, bicuculline (10 µM, Fig. 5.1B).

DHPG application increases sIPSC frequency
The mean sIPSC frequency recorded in normal aCSF was not different between
control (5.3 ±0.3 Hz) and PMG (4.9 ±0.7 Hz) populations, nor was there any difference
in the amplitude of isolated (Type I) events (Fig. 5.2). To activate group I mGluRs,
DHPG (10 µM) was applied with a local perfusion system that bathed ~300 µm around
the recorded cell. As expected, this caused an increase in sIPSC frequency in both
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control and PMG neurons (Fig. 5.2). Although both control and PMG cells responded to
DHPG, they did not respond equally. The mean percent increase in frequency, calculated
in individual cells, was much greater in PMG compared to control cortex (354 ±71 versus
195 ±43% for PMG versus control cells, respectively, t-test, p<0.05, Fig. 5.2F). While
most cells showed an increase in sIPSC frequency after DHPG application, a slight
decrease in sIPSC frequency was observed in a small number of cells in both control (4
cells) and PMG (2 cells) cortex (Fig. 5.2G). Even when cells that did not respond to
DHPG are excluded, there is still a clear difference in the median values for PMG
compared to control (horizontal bars, Fig. 5.2G). The sIPSC mean amplitude (Type I
events) was unaffected by drug application for both control and PMG groups (Fig. 5.2E).
Here for DHPG and in all drug application cases, the sIPSC rise time and decay time
were unaffected by the drug application (t-tests, N.S.). In control cells for aCSF versus
DHPG, mean rise times were 2.3 ±0.05 versus 2.4 ±0.04 ms, and mean decay times were
15.5 ±0.3 versus 14.9 ±0.2 ms. In PMG cells for aCSF versus DHPG, mean rise times
were 2.4 ±0.1 versus 2.4 ±0.1 ms, and mean decay times were 16.0 ±0.2 versus 14.5 ±0.3
ms. There was also no significant difference between control and PMG groups for these
measures (t-test, N.S.).
Immunohistochemical studies indicate that mGlu1 receptors are located on SSpositive, LTS-type interneurons (326). For this reason we expected that the effect of
DHPG was due to interneuron activation by mGluR1s. To confirm this, the mGluR1specific antagonist AIDA was added to the local application of DHPG. At 300 µM,
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AIDA significantly reduced the DHPG effect in both control and PMG cortex (Fig. 5.2BD).

Effect of DHPG with antagonists in the bath
To further examine whether DHPG was acting at mGluR1 or mGluR5, selective
antagonists for each were applied in the bathing medium. It was reported previously that
baseline glutamate levels can activate group I mGluRs in the same cell population we
studied here (16). However, in the presence of APV and DNQX used for these
experiments, sIPSC frequency and amplitude were not changed within the control or
PMG groups when mGluR antagonists were applied (MPEP, 10µM, AIDA, 100 µM or
300 µM, Fig. 5.3). When control and PMG groups were compared under these
conditions, only when MPEP was included in the bathing medium was there a difference.
In this case, the sIPSC frequency was significantly less in PMG cells compared to control
(Fig. 5.3C, t-test, p<0.05).
With the mGluR5 antagonist MPEP (10 µM) in the bathing medium, local DHPG
application still increased sIPSC frequency in both control and PMG cells, as expected
(Fig. 5.4). The percent increase in PMG cortex was not different from control (233 ±78
and 158 ±45% for 21 PMG and 21 control cells, respectively, t-test, N.S.). Under these
conditions, adding AIDA (300 µM) to the local perfusion of DHPG returned the sIPSC
frequency to near-baseline levels for both control and PMG cells (Fig. 5.4).
With the mGluR1 antagonist, AIDA (100 µM) in the bathing medium, control
cells showed no change in sIPSC frequency during application of DHPG (Fig. 5.5A-C).

131
Surprisingly, for PMG cells under the same conditions, DHPG still caused a large
increase in sIPSC frequency (from 3.3 ±0.7 to 8.8 ±1.4 Hz, t-test, p<0.05, Fig. 5.5C,E).
The sIPSC frequency was reduced nearly back to the baseline value by subsequent MPEP
application (10 µM, Fig. 5.5C). This effect was even more convincing when 300 µM
AIDA was included in the bathing medium (Fig. 5.5D,F). In both cases of 100 and 300
µM AIDA in the bath, the percent change in sIPSC frequency after addition of DHPG
was significantly greater in PMG compared to control cells (Fig. 5.5E,F, t-tests, p<0.05).

CHPG: mGluR5 selective agonist
To confirm that mGlu5 receptors activate interneurons in PMG, but not control
cortex, the mGluR5 specific agonist CHPG was applied through the local perfusion
system, with normal aCSF bathing medium. In PMG cortex, CHPG (750 µM) caused a
significant increase in sIPSC frequency that was reversed by MPEP (10 µM) application
(Fig. 5.6A). CHPG did not affect sIPSC frequency in control cortex (Fig. 5.6B). Similar
to the results for DHPG, sIPSC amplitude, rise time and decay time were also unaffected
by CHPG application. In control cells for aCSF versus CHPG, mean amplitudes were
25.3 ±3.0 versus 20.8 ±1.3 pA, mean rise times were 2.3 ±0.03 versus 2.4 ±0.1 ms, and
mean decay times were 14.0 ±1.1 versus 13.2 ±1.1 ms. In PMG cells for aCSF versus
CHPG, mean amplitudes were 33.1 ±2.9 versus 36.85 ±11.3 pA, mean rise times were
2.2 ±0.1 versus 2.2 ±0.1 ms, and mean decay times were 14.6 ±0.7 versus 14.3 ±1.0 ms.
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DHPG activates LTS but not FS cells
Although previous studies have shown that group I mGluR agonists activate LTS
but not FS cells (27), it was necessary to confirm that this selectivity is not altered in
PMG cortex. To verify this, current clamp recordings were made from interneurons
before and during DHPG application in control and PMG cortex. Interneurons were
initially selected based on their appearance under DIC optics. Cells having an oval or
elongated soma and appearing to have thick processes directed toward both the pia and
the subcortical white matter were suspected LTS neurons. Cells having a small, round
soma with multiple processes and/or a thin dendrite directed toward the pial surface were
suspected FS neurons. Interneuron subtype was confirmed based on the action potential
firing pattern. As previously described, FS interneurons had a brief action potential (<1
msec), and showed little adaptation during a 400 msec depolarizing current pulse
injection (Fig. 5.7B). In contrast, LTS interneurons had longer action potentials and fired
at high frequencies initially, with slowing frequency during a long current injection (Fig.
5.7A). These cells showed the same previously reported difference in the peak of the
afterhyperpolarizations (AHP) for a long spike train, namely that the first AHP was more
hyperpolarized than the rest (28). Cells identified as LTS in control cortex responded to
DHPG application with abrupt depolarization, a noticeable increase in baseline noise and,
in some cells, action potential firing (Fig. 5.7A, C). The same was true in PMG cortex
(Fig. 5.7B). In contrast, FS cells in both control and PMG cortex demonstrated only
slight depolarization, no increase in noise and no action potential firing in response to
DHPG (Fig. 5.7B,C).
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Although these results suggest that the increased response of PMG cells to DHPG
was due in part to mGluR5 receptors, it could also be caused by an increased sensitivity
of mGluR1 receptors on PMG interneurons. To test this idea, the magnitude of the
DHPG-elicited depolarization of interneurons was examined during application of
varying concentrations of DHPG. We measured both the peak and the ‘steady-state’
(observed after >1 min of application) depolarization. LTS cells responded to increasing
concentrations of DHPG with increasingly larger depolarizations, reaching the maximum
response at 100 µM. In addition, membrane oscillations were induced in the majority of
LTS interneurons in both control and PMG cortex, with concentrations of DHPG of
10µM and greater (80% of 15 control and 89% of 19 PMG cells). The dose-response
curves of the peak and steady-state membrane potential change suggest that there was no
change in the sensitivity of mGlu1 receptors in PMG cortex relative to control cortex, for
either LTS or FS interneurons (Fig. 5.7D, E).

A two-way ANOVA showed a significant

difference for concentration in LTS cells, but no difference between control and PMG
populations and no interaction between concentration and subject group (p <0.05 was
used for significance). For FS interneurons, the two-way ANOVA showed no significant
differences for either concentration or subject group or for interaction between these two.

Discussion
These data show that group I mGluRs activate inhibitory cells with greater
efficacy in PMG cortex than in control and that this increase is due to mGluR5 in
addition to mGluR1.

The mGluR5s are either not present or not functional on
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interneurons in control neocortex.

The LTS but not FS interneurons mediate this

response in both control and PMG cortex, with no change in mGluR1 sensitivity. This is
the first demonstration of a change in mGluR in this model, although increased mGluR
have been shown in dysplastic cortex from epilepsy patients (8; 11; 58).
The DHPG-induced increase in sIPSC frequency was nearly twice as large in
PMG as in control cortex when ionotropic glutamate receptors were blocked. Based on
current treatment strategies for epilepsy that involve augmentation of GABAergic activity
in the cortex, we would expect increased inhibition to reduce seizure activity and
counteract hyperexcitability. However, increased susceptibility to seizures seen in some
animal strains has actually been associated with enhanced inhibition (183; 338).
Furthermore, some antiepileptic drugs have even been shown to exacerbate seizure
activity, one of them through activation of GABA receptors (196).

In addition,

interneurons do not contribute equally to inhibitory function, as varying morphologies,
connectivity, and target domains dictate the type of influence interneurons have in the
cortex (28; 131; 173; 174). Whether or not the functional alteration promotes seizure
activity will likely depend on the type of interneuron that is affected (36; 183). Our data
suggest that release of glutamate that reaches extrasynaptic receptors will cause a
selective increase in LTS interneuron activation. Activation of LTS neurons through
group I mGluR has previously been shown to cause synchronous oscillations in
surrounding neocortical pyramidal neurons (27). Small changes in the level of mGluR
activation can also significantly affect thalamocortical rhythms (102). We hypothesize
that the increase in mGluR5 function in PMG cortex will increase synchronization of
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pyramidal neurons under conditions of high levels of excitatory activity and thereby
actually promote epileptiform activity. Tests of this hypothesis are currently underway.
The degree of control of inhibitory neurons exerted by group I mGluRs will
depend on the overall level of excitation in the neocortex. In this study, none of the
group I mGluR antagonists decreased sIPSC frequency in the absence of applied agonists
for control or PMG (Fig. 5.3), indicating that under these conditions ambient glutamate is
not sufficient to activate group I mGluRs. This is most likely due to the fact that
ionotropic glutamate receptors were blocked for this study, reducing overall levels of
neuronal activity. Others have shown that group I mGluRs are active when ionotropic
glutamate receptors are unblocked (16), suggesting that action potential-driven release of
glutamate, plentiful in hyperexcitable cortex, is necessary to stimulate the mGluRs.
Under normal slice conditions, IPSC frequency is decreased after addition of ionotropic
glutamate blockers. It was previously shown that the decrease in sIPSC frequency is
significantly greater in PMG than control cortex (158). It is possible that this is due to
not only an increased excitatory drive onto the interneurons, but also the decreased
activation of the extrasynaptic mGluRs. Anatomical studies have also suggested that
excitatory afferents are increased in the PMG (158; 159; 286). Therefore, mGluRs are
likely to be even more active in vivo in the malformed cortex. Interestingly, the sIPSC
frequency is slightly but significantly lower in PMG compared to control neurons when
MPEP is included in the bath. This difference, possibly due to an inverse agonist action
of MPEP (205; 245), supports the assertion that the observed sIPSC frequency difference
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in PMG versus control is likely due to the atypical presence of mGluR5s on PMG
interneurons.
The mGluR1 antagonist AIDA (300µM) reversed the effect of DHPG, both in
control and PMG cortex. This occurred in normal aCSF and when MPEP was included
in the bath solution, indicating that mGluR1 is sufficient to mediate the response to
DHPG. These results are in agreement with previously reported data that show mGluR1
alone can mediate increased sIPSC frequency in CA1 pyramidal cells following DHPG
application (207). Therefore, it is possible that an enhanced mGluR1 response could
contribute to increased activity in PMG. However, with mGluR5 blocked, dose-response
curves for DHPG showed no difference between the control and PMG LTS responses
(Fig. 5.7). A left shift in the curve would have indicated increased sensitivity of the
mGluR1 receptors, while a larger maximum response would have suggested an increased
number of receptors. Neither was observed, so it seems unlikely that the higher level of
activity is due to either of these factors. As appears to be the case here, mGluR1 and
mGluR5 are sometimes expressed in the same cell types and even in the same individual
cells (262; 355).
In many cases activation of mGluR1 and mGluR5 produce similar responses
through a similar mechanism (260; 261; 303), suggesting that synergism of their dual
activation may contribute to the overall effect (327). In fact, activation of both mGluR1
and mGluR5 is necessary to mediate DHPG-induced bursting behavior in hippocampus
(327). Both mGluR1 and mGluR5 have roles in LTP in the hippocampus (236; 344), as
well as in neocortical layer V (358).

However, it has been shown that specific
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mechanisms of action may actually allow them different, if overlapping, roles (365). In
CA1 pyramidal cells, mGluR1 mediates DHPG-induced depolarization, while mGluR5
contributes to increased excitability through decreased IAHP and potentiation of the
NMDA-R response (207). Also, mGluR5 has been shown to increase the excitability of
layer V pyramidal cells, specifically by decreasing AHP duration (325).

This is

particularly relevant, as we have observed decreased AHP duration in PMG LTS
interneurons (Chapter 2), perhaps caused by the same mechanism.

In hippocampal

interneurons expressing both receptor subtypes, it is mGluR5 that is responsible for acute
enhancement of epileptiform bursts, while mGluR1 is necessary to maintain long term
neuronal excitation (222). Furthermore, currents specific to each type of receptor show
differing kinetics in hippocampal interneurons. Activation of mGluR1 have been shown
to cause large, fast-rising calcium transients, most likely due to influx of extracellular
calcium, while activation of mGluR5 caused small, slow-rising calcium transients
abolished by depletion of internal calcium stores (350). There is also evidence for a Gprotein-independent mechanism of mGluR1 signaling in hippocampal mossy fiber
terminals (150).

Both of these receptor types have been implicated in oscillatory

membrane activity for hippocampus and neocortex (41; 362), but activation of mGluR5
specifically has been shown to recapitulate the oscillatory activity seen in immature tissue
(113). Alternatively, in cholinergic basal ganglia neurons, DHPG application combined
with mGluR5 blockade uncovered oscillatory activity, apparently driven by mGluR1 and
dependent on both L-type Ca2+ channels and tyrosine kinase (43). The roles that each of
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these subtypes play in oscillations and epileptiform activity in PMG cortex will require
further investigation.
Previous findings have demonstrated that LTS cells, but not FS cells, are the
interneuron subtype activated by DHPG in control cortex (27).

According to

immunohistochemical analyses, one to five percent of the cells in neocortex contain
mGluR1 (107), and the mGluR1 immunopositivity is observed in interneurons (256).
Two separate immunohistochemical studies have shown that in neocortex, mGluR1
colocalizes with SS (24; 326), found in LTS cells (174), but not PV (326). Here we have
shown that the selective functional expression of group I mGluR on LTS interneurons is
maintained in PMG cortex (Fig. 5.6). This suggests that the expression of these receptors
develops prior to or is simply impervious to the P1 lesion. In contrast to this is the
persistence of mGluR5 expression, possibly representing the maintenance of an immature
state. The mGlu5 receptors are expressed early in development and decline within layer
V during the second postnatal week, ultimately reaching a low level in all layers in adult
cortex (198). Previous work has characterized malformed cortex as having persistent
immature qualities that last beyond their typical chronological endpoint (62; 158; 290;
331). Some intrinsic properties also lag behind, such as action potential half-width and
firing frequency (201).
It is also possible that rather than maintaining a high state that the mGluR5 are
specifically upregulated, perhaps as a compensatory response to high levels of activity.
Recent studies have demonstrated that group I mGluRs are aberrantly expressed in tissue
from individuals with epilepsy and in various epilepsy models. For example, in patients
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with intractable temporal lobe epilepsy, upregulation of mGluR5 immunoreactivity in
hippocampus has been demonstrated (166). Conversely, following status epilepticus in
the pilocarpine model of epilepsy, there is a downregulation of mGluR5 mRNA (182).
In humans with Taylor-type focal cortical dysplasia, an increase in mGluR1 has been
shown in heterotopic neurons and dysplastic cells, along with an increase in neuronal and
glial mGluR5 expression (8).

In the kindling model of epilepsy, mGluR1 but not

mGluR5 transcript was increased in dentate gyrus (40). Additionally, in a rat model of
spontaneous seizures, mGluR5 expression was increased in reactive glial cells (10).
Studies mapping protein levels and functional activation of these receptors to changes in
cortical activity will be necessary to elucidate whether abnormal mGluR5 function
contributes to onset of or occurs in response to epileptiform activity.
Together, the observed increase in sIPSC frequency and the selective activation of
LTS cells suggest that the effectiveness of vertically projecting interneurons following
group I mGluR activation with DHPG will be enhanced when glutamate levels are high
enough to reach extrasynaptic receptors. Zhou and Hablitz have argued that increased
excitation, leading to increased glutamate release and mGluR activation, ultimately
results in increased inhibitory feedback to pyramidal cells (373). With regard to the data
presented here, the presence of mGluR5s on LTS interneurons could potentially focus the
augmented inhibitory feedback into a selective increase in vertical inhibition.

This

represents a mechanism for promoting synchronous activity between layers and within
cortical columns, and thereby enabling the initiation of epileptiform activity. It has
already been demonstrated that activation of group I mGluRs results in pro-convulsant
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activity, while specific antagonists to both mGluR1 and mGluR5 have anti-convulsant
activity in vivo (5; 96; see 229). Agonists of group I mGluR injected intracerebrally
cause limbic seizures (347; 348) that can be blocked with mGluR1 antagonists (22; 181).
DHPG applied in hippocampal slices produce long lasting epileptiform activity (167;
167; 221; 222). Antagonists of either mGluR1 or mGluR5 can block induction of this
epileptiform activity (167).
Because clinical trials are currently underway to test mGluR5 antagonists in
patients with Fragile X syndrome, it is likely that we will soon know whether these
compounds are an effective antiepileptic drug for a neuro-developmental disorder. Our
work suggests that they may also be an effective drug for malformation-associated
epilepsies (69).
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Table 5.1 Intrinsic properties of layer V pyramidal cells.
Parameter
Resting membrane potential,
mV
Input resistance, MΩ

Control

PMG

-55.8 ±0.7 (93)

-52.4 ±0.8 (83)

111.7 ±6.3 (93)

110.8 ±5.0 (83)

Time constant (τ), ms
1.8 ±0.05 (93)
1.9 ±0.06 (83)
Action potential amplitude,
101.9 ±0.6 (92)
102.1 ±0.5 (82)
mV
All data are expressed as means ±SEM (n cells). There were no differences between
control and PMG on any of these measures (t-test, p<0.05).

142

Figure 5.1 A. Pyramidal cell in layer V of a horizontal slice, imaged using DIC optics.
Image through two focal planes from dorsal (left) to ventral (right). Apical dendrite
apparent in left image (arrow), basal dendrites apparent in right image (arrowheads). B.
Sample traces demonstrating that recordings are isolated GABAA currents. B1a. Cell 1,
recording of sIPSCs in APV and DNQX. B1b. Recording from the same cell as in 1a,
during application of 10 µM bicuculline. The sIPSCs are abolished. B2a. Cell 2,
recording of sIPSCs in APV and DNQX. B2b. Recording from the same cell as shown in
2a, following addition of DHPG. B2c. Recording from the same cell as shown in 2a and
2b, during application of 10 µM bicuculline. This demonstrates that sIPSCs induced by
DHPG are abolished by the GABAA antagonist, bicuculline.
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Figure 5.2 Effect of DHPG (10 µM) and AIDA (300 µM) on sIPSC frequency and
amplitude. A. Sample traces demonstrating that DHPG affected IPSC frequency within
seconds of application in both control (1) and PMG (2). DHPG was applied at the
beginning of the recording. Files showing onset were not used for further analysis. B-C.
Typical traces from analyzed files for one control (B) and one PMG (C) cell. Traces
shown are for the following conditions: normal aCSF (B1, C1); local application of
DHPG (B2, C2); and local application of DHPG + AIDA (B3, C3). D. Mean sIPSC
frequency before (aCSF) and during application of DHPG or DHPG and AIDA. For
control (gray bars): naCSF = 42, nDHPG = 42, nAIDA = 13. For PMG (black bars): naCSF =
31, nDHPG = 31, nAIDA = 11. * = Student’s t-test with Bonferroni correction, p<0.05. E.
Amplitude of Type I events before and during application of DHPG (no significant
differences). F. Percent change in sIPSC frequency after DHPG application, calculated
within individual cells in control (gray bar, n = 42) and PMG (black bar, n = 31) cortex.
* = Student’s t-test, p<0.05. G. Percent change in sIPSC frequency after DHPG
application for individual cells (gray symbols = control, n = 42; black symbols = PMG, n
= 31). Circles indicate an increase in frequency, triangles indicate no change or
decreased frequency. The “X” represents median for each group with all cells included,
while the horizontal bar represents median for each group excluding cells indicated by
triangles that fall below the dashed line. Even when cells that did not respond are not
included, there is still a distinct difference in the medians for control and PMG cells.
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Figure 5.3 Effect of Group I mGluR antagonists in bathing solution. A-B. Example
traces showing typical sIPSC recordings for control (A) and PMG (B) in aCSF (A1, B1),
100 µM AIDA (A2, B2), 300 µM AIDA (A3, B3) and 10 µM MPEP (A4, B4). C-D.
Mean sIPSC frequency (C) and amplitude (D) recorded in control (left) and PMG (right)
cells with either normal aCSF bathing medium, or with the addition of antagonists as
shown in the bathing medium. Number of cells for conditions of normal aCSF, 100 µM
AIDA, 300 µM AIDA, and 10 µM MPEP, respectively are: 42, 15, 10, 26 for control, and
31, 13, 21, 20 for PMG. One-way ANOVAs performed for each subject group (control,
PMG) across bathing conditions, showed that adding antagonists to the bathing medium
did not change the mean sIPSC frequency or amplitude. Student’s t-test was performed
to compare control vs. PMG for each bathing medium condition. MPEP showed a
significant difference (p <0.05), all others NS.
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Figure 5.4 Effect of DHPG on sIPSC frequency with MPEP (10 µM) in bath. A.
Mean sIPSC frequency in aCSF with MPEP in the bath, during local application of 10
µM DHPG application and during addition of 300 µM AIDA to DHPG local application.
* = t-test with Bonferroni correction, p <0.05. B. Percent change in sIPSC frequency
following addition of DHPG. There was no significant difference between control and
PMG cells (t-test, NS). C. Distribution of individual cell responses for percent change in
sIPSC frequency following DHPG application. Circles indicate an increase in frequency,
triangles indicate no change or decreased frequency. The “X” represents median for each
group with all cells included, while the horizontal bar represents median for each group
excluding cells indicated by triangles that fall below the dashed line. There is little
difference between control and PMG groups whether or not the possible technical failures
(triangles) are excluded. In all cases, control data is shown in gray and PMG in black.
Data shown is for 26, 22, and 10 control, and 21, 21, and 8 PMG cells, under conditions
of aCSF, DHPG, and DHPG + AIDA, respectively.
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Figure 5.5 Effect of DHPG on sIPSC frequency with AIDA (100 µM or 300 µM) in
bath. A-B. Sample traces showing typical sIPSC characteristics for control (A) and
PMG (B) under the following conditions: (1) aCSF with 100 µM AIDA in the bathing
medium; (2) same as 1, but during local application of 10 µM DHPG; and (3) during
addition of 10 µM MPEP to the local perfusate (DHPG also in local perfusate for 3). C.
Mean sIPSC frequency for conditions described in 1-3 above (control, gray bars, PMG,
black bars), with 100 µM AIDA in the bathing medium. Number of cells recorded for
these three conditions was 15, 10, and 5 in control and 13, 10, and 7 in PMG cortex. * =
t-test with Bonferroni correction, p <0.05. D. Mean sIPSC frequency for conditions
described in 1-3 above, with 300 µM AIDA in the bathing medium. Number of cells
recorded for these three conditions was 10, 8, and 2 in control and 21, 17, and 13 in PMG
cortex. * = t-test with Bonferroni correction, p <0.05. E-F. Percent change in sIPSC
frequency following addition of DHPG in bathing conditions of either 100 µM AIDA (E,
control, n = 9; PMG, n = 10) or 300 µM AIDA (F, control, n = 7; PMG, n = 15). * = ttest, p <0.05.
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Figure 5.6 Effect of CHPG on sIPSC frequency. A. Change in sIPSC frequency
following local application of 750 µM CHPG in PMG cortex. Results shown are for 6
PMG cells in conditions of normal aCSF, during CHPG application and during the
addition of the MPEP to the CHPG application. B. Same as in A, but for control cells.
MPEP was not applied here because there was no effect of CHPG. Results shown are for
5 control cells in conditions of normal aCSF and during CHPG application. * = t-test, p
< 0.05.
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Figure 5.7 Response of FS and LTS interneurons to DHPG application. A. Example
LTS interneurons from control (A1) and PMG (A2) cortex. Firing pattern in response to
an intracellular depolarizing current pulse (400 msec) is shown at left. Response to 10
µM DHPG (local application) shown at right. Cells depolarized within seconds of DHPG
application (at beginning of trace). B. Example FS interneurons from control (B1) and
PMG (B2) cortex. Response to DHPG was a slight membrane depolarization (right). C.
Example LTS (C1) and FS (C2) cells demonstrating characteristic responses to 100 µM
DHPG. The LTS cell depolarized within seconds and then fired action potentials
following application of DHPG (beginning of trace). D. Maximal depolarization
occurring after DHPG application. E. Steady-state depolarization observed after >1 min
of DHPG application. There were no significant differences between control and PMG
cells. F. Example of membrane oscillations induced in an LTS interneuron.
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Chapter 6
General Discussion

For decades, the dogma in epilepsy treatment and research has been that seizures
are due to increased excitation or decreased inhibition. Within this framework, and
despite advances in the diagnosis and treatment of epilepsy, modern medicine has not
been able to counteract mechanisms of neocortical hyperexcitability for many patients.
In order to successfully treat patients with intractable seizures, particularly those
associated with malformations of cortical development, it is necessary to understand all
the factors that contribute to abnormal cortical function. Past epilepsy research has
investigated the role of increased pyramidal cell activity and bursting behavior in both
hippocampal and neocortical models of epilepsy. Recent work from this lab has
demonstrated that increased excitatory input to pyramidal cells occurs in the freeze-lesion
model of cortical hyperexcitability used for the studies described here. Of particular
relevance to the experiments described in this body of work is the fact that the observed
increase occurs prior to the onset of epileptiform activity, indicating that there are other
factors involved in controlling or “masking” it (375). The experiments described here
focused on the role of neocortical interneurons in epileptogenesis, as several aspects of
their development reach mature levels around the time epileptiform activity can be
evoked in this model. In recent years, increased attention has been focused on the
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networks of inhibitory cells that are responsible for regulating excitation. This is because
the pattern of excitatory output may be as important as the magnitude, with regard to
abnormal synchrony and seizure activity. In fact, some studies have shown that
excitation occurs in the presence of maintained, even enhanced, inhibitory function (206).
The work presented in this dissertation was performed to increase our understanding of
the seemingly paradoxical contribution of GABAergic inhibitory cells to neocortical
hyperexcitability and epileptogenesis.
A number of the properties responsible for stereotypical characteristics of FS and
LTS interneurons were evaluated in the preceding chapters. These two interneuron
subpopulations form separate networks of electrically interconnected cells, and due to
their distinct characteristics, it has been suggested that these networks also have separate
functional roles in the cortex (131). In addition, morphology indicates that the network
of vertically extended LTS cells is capable of providing intracolumnar inhibition, while
horizontally oriented FS cells provide intralaminar inhibition. Alterations to either
subtype could affect these specific roles, leading to the overall hypothesis that in PMG
cortex, increased efficacy of LTS cells and decreased efficacy of FS cells create a
synchrony-promoting imbalance of neocortical inhibition. The results presented in the
preceding chapters suggest that interneuron subtypes are differentially altered in a
manner that could cause abnormal synchrony in epileptogenic cortex. Specific findings
that support this include: (1) increased firing frequency in PMG LTS cells and a parallel
decrease in PMG FS cells, (2) increased excitatory input to PMG LTS cells, and (3)
increased inhibitory output in PMG cortex when LTS cells are selectively activated.
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As demonstrated in chapter 2, interneuron subtypes can be clearly identified in
PMG cortex. This was accomplished using the same classification criteria as in control, a
critical point, as the significance of altered connectivity depends on the maintenance of
properties that endow interneuron subtypes with their specific functions. Intrinsically
altering these subtypes could change the function of individual cells, as well as the entire
network to which they belong. This would make evidence of other types of changes
difficult to interpret. Abnormal cell types have been demonstrated in animal models and
in human cases of epilepsy (62), so defining these interneuron populations for the freezelesion model was necessary to validate these and future studies that intend to exploit the
differences between them. In addition to this observation, the findings in chapter 3
demonstrate that LTS interneurons receive more excitatory input in PMG. This suggests
that they may be depolarized to action potential threshold more frequently than their
control counterparts. In combination with the fact that PMG LTS interneurons also have
an increased firing frequency (Chapter 2), these data suggest that LTS interneurons are
likely excited with greater frequency and to a greater extent in PMG cortex. As a result,
the network of LTS cells may exert more powerful inhibition in PMG cortex than in
control. In contrast, the input to FS cells does not appear to be altered. However, the
results from chapter 2 show a lower action potential firing frequency for FS cells in
PMG. This is interesting because decreased PV expression also suggests that there is a
selective loss of FS cells in this model (288). The presence of fewer cells, combined with
a lower firing frequency for the cells that remain, indicates that a decrease in the overall
efficacy of FS cells is likely.
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The current working hypothesis based on these data is that (1) increased input and
excitability enhance LTS output, increasing columnar synchrony, and (2) diminished
excitability and cell number cause a decrease in FS output, permitting the spread of this
synchrony to neighboring columns. Postsynaptically, this mechanism would result in
more LTS-generated sIPSCs in pyramidal cells, but fewer FS-generated sIPSCs.
Although it would likely involve complex analysis, the veracity of this hypothesis could
be assessed on a cellular level by evaluating pyramidal cell sIPSCs. As has been
discussed in chapter 1, vertically-oriented LTS cells synapse on the dendrites of their
post-synaptic targets, while FS cells synapse on the soma. Somatic and dendritic IPSCs
can be differentiated from each other with intracellular recordings (81). Unless the target
domains of interneuron subtypes are also altered in this model, this would provide a
means to compare input based on the inhibitory cell type. An increase in the frequency
of dendritic events and a comparable decrease in the frequency of somatic events would
simultaneously support this hypothesis and permit the overall frequency of IPSCs to
remain unaffected. IPSC kinetics may be helpful in differentiating the source of IPSCs;
however, this also reflects synapse location and is not necessarily specific to the
presynaptic cell type. For example, increased dendritic inhibition could signify increased
output from the typical dendrite-targeting cell population, or it may reflect a
reorganization of inhibitory outputs that previously targeted the soma. However, were
this observation to be made in conjunction with the data presented here, it would strongly
support the presence of increased LTS output. In PMG cortex, if LTS inhibition is more
readily activated, the very same inhibitory pattern that is seen in control could be applied
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to PMG pyramidal cells, only with greater strength. Following the cessation of this
powerful inhibition, depolarizing glutamatergic inputs would simultaneously bring the
previously hyperpolarized cells to threshold potential. Repetition and magnification of
this cycle through feedback inhibition would allow this synchronous activity to persist.
In this study, to assess whether or not the output of LTS interneurons was
enhanced in PMG cortex, this cell type was selectively activated with a group I mGluR
agonist, and sIPSCs recorded from pyramidal cells were compared between control and
PMG. Perhaps the most important finding discussed in chapter 5 is that the response to
this activation was twice as large in the PMG cortex. Further investigation revealed that
this could be attributed to increased agonist sensitivity, due to mGluR5 activation that
does not occur in control. This increased inhibitory output is consistent with the
increased LTS firing frequency and excitatory input described in chapters 2 and 3.
Further, the release of extra glutamate in PMG cortex, due in part to an increased number
of excitatory terminals, may activate mGlu5 receptors on PMG LTS cells. Although the
experiments in chapter 5 indicate that the group I mGluRs are not active in response to
spontaneous glutamate release when ionotropic receptors are blocked, mGluRs have
demonstrated activity in response to ambient glutamate when the ionotropic receptors are
not blocked (16). Interestingly, activation of mGluR5 has also been shown to increase
firing frequency and decrease AHP duration (325), two effects also seen in PMG LTS
cells (Chapter 2). While these data do not definitively establish a causal relationship
between increased input to and output from LTS, together they makes a strong case for
the increased efficacy of the LTS population
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Future experiments that may complement these findings
These studies reveal functional changes likely to promote epileptogenesis, but an
even stronger argument for these underlying mechanisms could be made with
accompanying structural evidence. Immunohistochemcal results suggest that the
rearrangement of afferent fibers occurs in this model (159; 286). Additional studies using
electron microscopy to look specifically at the number of excitatory synapses on
interneurons would help clarify the organizational pattern. It is also possible that not all
of the relevant changes are reflected anatomically. For example, if release probability is
altered but not detected by the methods of this study, a significant increase in the number
of synapses may not be observed, even at the ultrastructural level. Despite this, based on
current immunohistochemical and physiological data, it is probable that this type of study
would demonstrate an increase in the number of excitatory afferents to some interneurons
and most pyramidal cells of layer V somatosensory cortex.
The findings from chapter 5 provide a convincing argument for the presence of
functional mGluR5s on the PMG LTS interneurons, but several different approaches
could be taken in order to visually confirm what the physiological data suggest. As has
been performed in a number of other models and disease states, in situ hybridization
could be used to demonstrate upregulation of mGluR5 mRNA. To establish an estimate
of whether or not the protein is increased in PMG, a western blot could be used to
compare levels in control and PMG. Development of a good mGluR5 antibody to be
used for immunohistochemistry would also permit visible co-localization of these
receptors with other LTS cellular markers in PMG. Visualizing these receptors is
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important, though, because the possibility remains that mGlu5 receptors are present but
not functional in control. Alteration of a single subunit could provide the functionality
that is exclusively demonstrated in PMG cortex. This type of information would direct
future studies, differentiating between the utility of an mGluR5 knockout or a more subtle
experimental designed to detect the presence of specific subunits.
To determine whether any or all of these observed changes contribute to cortical
synchrony, it is necessary to perform experiments at a higher level of organization than
the single cell. Field potential recordings are ongoing in the lab to assess whether the
coordinated activity of LTS interneurons results in synchronous firing within cortical
columns in the paramicrogyral region.

Translation and Therapeutic Relevance
Current anti-convulsive treatment for most patients with epilepsy involves the use
of drugs with varied mechanisms of action, but all of them decrease excitatory cellular
activity or increase inhibition. Phenobarbital and benzodiazepines, some of the first
drugs used to treat seizures, bind the GABAA receptor to prolong or increase the
frequency of channel opening, respectively. Several anti-seizure medications target
specific membrane channels. For example, pregabalin binds a subunit of voltage-gated
calcium channels and has effective anticonvulsant activity in electroshock, kindling and
some chemically-induced seizures (31). Specific blockade of voltage sensitive sodium
currents by lamotrigine prevents high-frequency firing, circumventing an excitatory
overload (216). Zonisamaide also blocks sodium channels but has demonstrated activity
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on the T-type calcium current as well (193). Other mechanisms of anticonvulsant action
include inhibition of GABA reuptake by tigabine (301) and reduction of IP3-dependent
calcium release by levetiracetam (57).
While these drugs have a fairly good success rate for treating some seizures, they
fail for others. In addition, polypharmacy is often the only way to effectively limit
seizure activity in some patients. When this fails, the only recourse for patients with
intractable epilepsy may be invasive surgery. Even when the anti-epileptic drugs are
effective, side effects may be prohibitive. Drug interactions may be especially
problematic for AEDs, as their long-term use is often necessary for enduring remission of
seizures. The possibility of using mGluR5 as a target for the development of new
pharmacotherapy is attractive, because this receptor is not normally expressed at high
levels in the developed brain. As a result, antagonism of mGluR5 may not cause the
extensive side effect profile of some other anticonvulsants.
In vivo experiments have determined that mGluR5 antagonists have
anticonvulsant properties. This may be due to a dampening effect on pyramidal cell
activity, and therefore has the potential to be at least partially successful in a number of
models. Based on the observations in this model, an mGluR5 antagonist may also be able
to decrease activity in one subset of interneurons, potentially counteracting the
development of synchronous activity. If this type of mechanism translates to the human
condition, antagonism of mGluR5 could have a synergistic effect, potentially resulting in
successful seizure control in this type of epilepsy.
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